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ABSTRACT
A Cross-Sectional Study Examining Lifestyle and Rheumatoid Arthritis
by
Leslie Nazaroff, MPH, DrPH
Doctor of Public Health in Preventive Care
Loma Linda University, Loma Linda, California - 1998
Associate Professor Helen Hopp Marshak, Chairman

Abstract
Obiective. Rheumatoid arthritis (RA) is a chronic inflammatory disease that
affects the synovial joints. RA affects 0.5-2% of the population. Though it is
predominantly a progressive disease, adjunct therapy may slow the destructive pathway
or alleviate affiliated symptoms. This study examined the effects of lifestyle (diet and
exercise) and self-efficacy on symptoms of RA as measured by disease activity and
health satisfaction.
Methods. Seventy-five RA patients (77% female) from the Loma Linda
University Faculty Medical Offices, Rheumatology Department completed selfassessment surveys on their lifestyle practices and RA affliction. Disease symptoms
and activity were assessed with the Arthritis Impact Measurement Scales-symptoms
(pain) component (AIMS2) and the Rapid Assessment of Disease Activity in
Rheumatology (RADAR). Subjects also completed a RA self-efficacy scale and three
outcome expectation items and questions that assessed their exercise patterns, dietary
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intake and current use of RA medication.
Results. Stepwise regression analysis revealed that, after controlling for
demographics (n=60), high self-efficacy was associated with significantly fewer RA
symptoms (AIMS2 [R2=.43; F (1,60) 6.06, p=.00001]; RADAR [R2=.59; F (1,60)
10.69, p^.000000004]) and greater health satisfaction (R2=.31; F [1,60] 4.39, p=.0002).
A healthier diet was also associated with significantly greater health satisfaction.
Separate analysis was conducted among exercisers due to the unique patterns
and differences compared to all subjects. Among RA subjects who exercised (n=43).
those who had higher self-efficacy and exercised more frequently had less pain
(R2=.44; F [1,43] 4.31, p=.001). Higher self-efficacy was associated with less disease
activity (R2=.49; F [1,43] 5.62, p=.0001). Exercisers with high self-efficacy and a
strong belief that exercise can reduce the symptoms of RA reported greater health
satisfaction (R2=.54; F [1,43] 5.51, p=.0001).
Conclusions. Results suggest that RA patients with greater self-efficacy report
more favorable RA disease activity scores. Patients who followed a healthy diet and
who exercised experienced improved RA outcomes. Future research should include
diet and exercise recommendations and techniques for improving self-efficacy among
RA patients.
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CHAPTER ONE: INTRODUCTION
Definition of the Problem
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune
disease that affects approximately .5-2% of the adult population over 18 years of age
(Kwol, Simms, Anderson, Erlandson, Greene, Moncuret, ah, 1996; Pincus, 1995;
Wilske & Yocum, 1995). Females are inflicted with this disease two to three times
more often than males, and Caucasians are affected more frequently than other races.
Fries (1996) estimates that a typical patient with rheumatoid arthritis will visit their
doctor 200 times over the average 25 year span of disease management. Chronic
rheumatoid arthritis leads to erosion of bones and eventual loss of function. The
disease frequently affects the joints of wrists, hands and feet, but often involves other
sites. Physical disability is a typical result of chronic RA. Patients experience severe
pain at various stages of the disease span, and long-term use of medications can also
lead to complications in many cases, such as chronic nephrotoxicity or gastrointestinal
complications (Segasothy, Chin, Sia, Zulfiqar, & Samad., 1995; Simms, Kwoh,
Anderson, Erlandson, Greene, Kelleher, et al., 1996; Singh, Ramey, Morfeld, Shi,
Hatoum, & Fries, 1996).
There are non-medical alternative treatments available to treat RA symptoms.
Coping skills are beneficial in RA disease management, especially related to pain
control (Bueshcer, Johnston, Parker, Smarr, Buckelew, Anderson, et al., 1991). Diet
may reduce the inflammatory disease process (Kremer, Bigauoette, Michalek,
Timchalk, Lininger, Rynes, et al., 1985; Panush, 1987). Exercise can enhance overall
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health and improve mobility during non-acute periods without increasing disease
activity (Danneskiold-Samsoe, Lynberg, Risum, & Telling, 1987). There have been
isolated efforts to introduce multi-discipline approach to helping patients with RA,
primarily through patient education (Davis, Busch, Lowe, Taniguchi, & Djkowich,
1994). However, research is needed that specifically addresses the relationship among
lifestyle factors and RA disease outcomes.
Preventive Care Perspective
Preventive Care Specialists are trained to assist patients with lifestyle changes
needed to prevent and/or manage chronic disease. Patients with chronic rheumatoid
arthritis have periods of temporary remission (defined as being symptom-free for at
least two months); however, after two or three years with the disease, patients are
likely to show signs of joint destruction (Stenstrdm, 1994). Preventive Care
Specialists can offer treatment alternatives of adjunct therapy for tertiary prevention to
minimize joint destruction. The independent effects of diet, exercise and efficacy
enhancing techniques, as alternative non-medical treatments to RA, have been studied
separately. These experimental treatments have been shown to be beneficial over
control groups in randomized trials (Kjeldsen-Kragh, Haugen, Borchgrevink, Laerum,
Eek, Mowinkel, et al., 1991; Parker, Smarr, Buckelew, Stucky-Ropp, Hewett,
Johnson, et al., 1995; Stenstrdm, 1994). These results indicate a need for Preventive
Care Specialists to utilize various modalities when treating patients with chronic
disease to optimize disease outcomes. Preventive Care Specialists are capable of
incorporating and evaluating lifestyle intervention on patient care. Working together

2

with the patient's primary care physician or rheumatologist, they can assist patients
with rheumatoid arthritis, enabling patients to maximize their personal efforts in
disease management through lifestyle interventions.
Purpose of the Study
The purpose of this study was to determine the degree of association among
medication use, the lifestyle factors of diet and exercise and symptoms of rheumatoid
arthritis. In addition, this study examined the relationship of self-efficacy and outcome
expectations to medication use, lifestyle and symptoms of RA.
Research Questions
It was hypothesized that rheumatoid arthritis patients who followed a diet lower
in fat and animal products and who performed regular exercise would report fewer
symptoms of RA. Further, it was predicted they would experience a higher degree of
self-efficacy in controlling their RA and stronger outcome expectations of fewer RA
symptoms due to their current lifestyle, compared to those following a diet higher in
fat and animal products and/or who engaged in no form of regular exercise.
The following questions were addressed in this cross-sectional study:
1)

To what degree is a lifestyle that incorporates a low-fat, low-meat diet
and regular exercise related to RA symptoms in patients with
rheumatoid arthritis?

2)

Do RA patients who follow a healthier lifestyle (e.g., one that includes
a low-fat, low-animal product diet and regular exercise) have higher
self-efficacy and outcome expectations than those who do not lead such
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a lifestyle?
3)

Do patients with higher self-efficacy and outcome expectations have
fewer symptoms of RA?

Theoretical Model
Theoretical models provide additional validation to research by revealing
relationships that might otherwise be undetected. As tangible evidence is uncovered
that associates certain predictors (e.g., diet and exercise) with symptoms of RA, a
theoretical model can help provide explanations for these relationships or determine
possible mediators to outcome measures.
Rheumatoid arthritis is a disease fraught with an abundance of symptoms and
debilitation of varying degrees over a period of time. This cycling from relative
stability to increased symptoms can be a tremendous emotional and physical burden on
the RA patient. A theoretical model was sought to explain the extent to which RA
patients with similar disease impact and disease activity would differ according to their
level of efficacy (e.g., the perception of being able to perform a behavior) in
controlling RA disease symptoms. Additionally, a model was needed to provide
guidance on how to assess outcome expectations. Theoretically, there would be no
benefit for the RA patient who had high self-efficacy in performing specific behaviors,
but felt that no improvement in the disease would result from engaging in those
behaviors.
Social cognitive theory. Bandura (1997) defines self-efficacy as a person's
perceived ability to perform a specific behavior. Accordingly, this self-perception
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needs to be high in order to attempt performance of the behavior (e.g., "I have
confidence that I can walk two miles daily"). Additionally, Bandura describes
outcome expectations as a persons degree of belief the performance will directly affect
their outcome (e.g, "Walking two miles a day will reduce my pain of rheumatoid
arthritis"). Bandura's Social Cognitive Theory was selected for this study to provide a
basis for examining this relationship between self-efficacy and outcome expectations,
and behavior performance. According to this theory, as self-efficacy to perform a
behavior increases, the likelihood of performing the behavior increases. As the
behavior is performed, outcome expectations increases, which will likely lead to
increased repetition of the behavior. As outcomes become more favorable, selfefficacy is strengthened. Thus, through positive feedback, a cycle develops that
enhances self-efficacy, primarily through repeated performance.
Several studies show that when patients had high self-efficacy fewer symptoms
related to rheumatoid arthritis resulted, such as less pain, disability, and depression
(Buescher, Johnston, Parker, Smarr, Buckelew, Anderson, et al., 1991; Daltroy &
Liang, 1991; Kjeldsen-Kragh, Haugen, Forre, Laache, & Malt, 1994; Newman, 1993;
Samuelsson, Ahlmen, & Sullivan, 1993; Taal, Rasker, Seydel, & Weigman, 1993).
Also, despite additional RA physical disability over time, when patients perceive
greater control over their disease through self-management techniques, pain scale
scores are lower compared to those who did not practice self-management techniques
(Lorig, Mazonson, & Holman, 1993).
In summary, in order for patients to adapt to lifestyles which involve behavior

5

changes such as, diet and regular exercise, according to the Social Cognitive Theory
they will need to believe that:
1)

they are able to perform these behaviors (self-efficacy), and

2)

these performances will lead to desired outcomes of reduced rheumatic
symptoms (outcome expectations).

Self-efficacy in RA patients has been studied fairly extensively, but
predominantly as it relates to coping and stress management (Buescher, et al., 1991;
Daltroy & Liang, 1991; Kjeldsen-Kragh, Haugen, et al., 1994; Newman, 1993;
Samuelsson, et al., 1993; Taal, et al., 1993; Lorig, et al., 1993). Little research has
been done to determine the association among self-efficacy, lifestyle and rheumatoid
arthritis symptoms. Further, most research based on the Social Cognitive Theory has
focused on the component of self-efficacy, not outcome expectations. Yet, high selfefficacy may not be enough to promote changes in lifestyle. Positive outcome
expectations of the behavior performance on improving RA symptoms will likely be
necessary for change to occur based on Social Cognitive Theory.
Though this study was not designed to test the Social Cognitive Theory, the
theory was included to examine the relationship among self-efficacy, outcome
expectations and lifestyle (specifically, diet and exercise) and symptoms of RA.
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DEFINITIONS & ABBREVIATIONS
Acute flares - Term used to describe symptoms of extreme pain and increased
inflammation beyond the normal course of RA disease progression.
Arthritis Impact Measurement Scales (AIMS) - (Meenan, Mason, Anderson, Guccione,
& Kazis, 1992). Self-assessment scale which measures rheumatoid arthritis
disease impact on rheumatoid arthritis patient, such as mobility or function
(refer to Appendix E).
Arachidonic acid - Fatty acid precursor to the predominant prostaglandins, which are
known to influence inflammatory response.
Atrophy - A process of wasting or diminishing.
Auranofin - is a gold salt classified medication used to treat rheumatoid arthritis.
Though the specific action is unknown, it is theorized that its anti-inflammatory
action is caused ny the inhibition of sulfhydryl systems which alters cellular
metabolism. This drug may also alter enzyme function and immune response
and suppress phagocytic activity.
Bonferroni - Controls overall error rate by setting the error rate for each test to the
experimentwise error rate divided by the total number of tests (Snedecor &
Cochran, 1989). Hence, the observed significance level is adjusted for the fact
that multiple comparisons are being made.
CHO - Carbohydrates.
Chronic RA - Form of rheumatoid arthritis that is non-reversible and progressive over
time.
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Corticosteroids - Family of drugs used to treat inflammatory symptoms of RA.
ESR - Erythrocyte sedimentation rate is a serum inflammatory marker for
inflammation frequently used to evaluate RA condition.
Food challenge - Introduction of a specific food after its initial elimination from the
diet to determine food sensitivity.
HDL - High-density lipoprotein. Lipoproteins function to keep lipids soluble as they
are transported through the plasma. They also remove unesterified cholesterol,
delivering them to the liver for conversion to less harmful particles.
Methotrexate - An antimetabolite drug used to treat rheumatoid arthritis. This
medication prevents folic acid from being reduced to tetrahydrofolate by
binding to dihydrofolate reductase. This is currently the most common
second-line drug used to alter rheumatoid arthritis disease.
Myelosuppression - suppressed production of stem cells that would lead to the
reduction of specific leukocytes: basophils, neutrophils and eosinophils.
Nalproxyn - A common NSAID used to treat RA.
NSAIDs - Non-steroidal-anti-inflammatory-drugs; used in treatment of inflammatory
symptoms of RA.
Omega-3 fatty acids - Fatty acids that promote the production of prostaglandins known
to reduce inflammatory responses in the body.
Outcome expectation - The belief that performance of a specific behavior (e.g.,
exercise) will lead to a desired outcome (e.g., reduction of rheumatoid arthritis
symptoms).
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Patient global assessment - Patient's subjective assessment of current rheumatoid
arthritis disease status (Refer to Appendix E, AIMS2- question 53).
Polypharmacy - Simultaneous regimen of multiple drug usage.
Prednisone - Most common corticosteroid used to treat RA.
Prostaglandins - Compounds found in most tissues that produce a variety of specific
physiologic responses, such as vasoconstriction, vasodilation, platelet
aggregation and increased vascular permeability. Certain prostagladins
stimulate inflammation (e.g., PGE2). RA medication, such as NSAIDs, target
to block the release of these inflammatory prostaglandins.
RADAR - Rapid Assessment of Disease Activity for Rheumatology. Self-assessment
tool that measures active disease activity in patients with RA. This includes
assessment of pain, tender joints and ability to function (refer to Appendix E).
Range-of-motion exercises - Stretching exercises that specifically take each joint
through its full range of motion.
RF -

Rheumatoid factor. This serum factor represents multiple antibodies,
principally IgM, which are associated with increased incidence of RA. It is not
necessary to test positive for RF to be diagnosed with RA.

Rheumatism - Outdated term used to describe joint ailments.
SAARDs - Slow-Acting-Anti-Rheumatic-Drugs; used in treatment to modify RA
disease pathogenesis by disrupting specific pathways. For example,
methotrexate disrupts purine synthesis thus lowering overall DNA synthesis,
slowing cell growth. This also causes a decrease in folic acid and warrants
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supplementation to replenish.
Second-line drugs - Medications used to combat RA disease process at the cellular
level. Synonymous with slow-acting-anti-rheumatic drugs (SAARDs).
Self-efficacy - A degree of confidence in a person's belief that a specific behavior
(e.g., swimming) can be performed, usually in a specific context (e.g., when
you are experiencing pain.
Synovial joint - The mobile joints in the body that possess a membrane and synovial
fluid (e.g., hand, knee, shoulder joints).
Synovitis - Inflammation surrounding the synovial joints.
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CHAPTER TWO: LITERATURE REVIEW
Overview
Defining rheumatoid arthritis. Though rheumatism has been described from as
early as the 1500s, rheumatoid arthritis was first described in 1800 and thought to be
associated with poverty (Schumacher, 1988). RA was believed to be a relatively
minor progressive disease, but is now recognized as serious and debilitating (Pincus,
1995). Over the years the disease process has been better defined and is now referred
to as a combination of clinical features (refer to Table 2.1 for inclusion criteria).
Pincus (1995) and Semble (1995) summarize current findings, associating RA with
severe morbidity, functional decline, and increased premature mortality.
Table 2.1

1988 Revised American Rheumatism Association criteria for the diagnosis of
rheumatoid arthritis (Arnett, Edworthy, Block, McShane, Fries, Cooper et al., 1988)

Four or more criteria must be present to diagnose rheumatoid arthritis
1.
2.
3.
4.
5.
6.
7.

Morning stiffness for at least one hour and present for at least six weeks.
Swelling of three or more joints for at least six weeks.
Swelling of wrist, metacarpophalangeal or proximal interphalangeal joints for six or more weeks.
Symmetric joint swelling.
Hand roentgenogram changes typical of rheumatoid arthritis that must include erosions or
unequivocal bony decalcification.
Rheumatoid nodules.
Serum rheumatoid factor by a method positive in less than 5% of normals.

Though adult RA can strike anytime after 18 years of age, it typically strikes
between the fourth and sixth decades of life (Schumacher, 1988). RA is an
inflammatory autoimmune disease with unknown etiology. Chronically, it can affect
the tissues surrounding synovial joints and lead to the destruction of cartilage,
ligaments, tendons and bone. Remission is uncommon in definitive RA, occurring in
less than 5-7% of patients and seldom lasting beyond 10 months (Wolfe, 1996).
Radiographic evidence of bone destruction can appear as early as 6-12 months from
11

the time of diagnosis which gradually progresses in a linear fashion and correlates
with the amount of functional disability the patient experiences (Scott, Coulton, &
Popert, 1986; Kwol, et ah, 1996). Early diagnosis is essential to increase the
probability of optimal response to medication and adjunct therapy thus minimizing or
slowing the destruction of joints and bones (Semble, 1995).
In 1996, the American College of Rheumatology Ad Hoc committee on clinical
guidelines for treatment of RA developed a flow-chart schematic diagram following a
patient from diagnosis of RA through the various stages of disease progression (Kwol,
et al., 1996). The primary focus of this diagram is directed toward disease arrest and
stabilization through various medication regimens and eventual surgical replacement of
debilitated joints. However, during the initial treatment phase, patient education,
physical and occupational therapy are mentioned as appropriate adjunct treatment
modalities. Because of the progressive and chronic nature of RA, it was important
that this committee recognized adjunct therapy as part of the overall treatment of the
RA patient. Though individual response to alternative treatments may vary, the
availability of various therapeutic modalities may help the RA patient who must come
to terms with the fact that there is currently no known cure for the disease.
The following literature review will focus on:
1)

medical and personal costs of the RA population;

2)

risks and benefits of long-term use of medication for RA;

3)

role of exercise in improving health and daily function; and

4)

dietary factors that improve disease outcomes.
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This review will demonstrate the need to examine the relationship between lifestyle
and RA symptoms in order to determine if alternative adjunct therapy in the treatment
of rheumatoid arthritis may also reduce RA symptoms and perhaps lead to the
reduction of medication use.
Impact of Rheumatoid Arthritis
Health care costs. Epidemiological studies have shown that, though the
number of patients with RA is relatively low, the health care costs per patient to treat
RA are high (Pincus, 1995). Summarizing findings from two large epidemiological
studies, Pincus (1995) found annual costs for medical treatment per RA patient ranged
from $4963 - $7259 U.S. dollars. Costs included: outpatient costs, physicians and
other professionals visits, laboratory tests, radiography, medications, devices, inpatient
costs, miscellaneous costs, transportation, and nontraditional therapies (one of the
lowest reported dollar figures). Though most RA is diagnosed in the third and fourth
decades, incidence (number of cases of persons who acquire RA divided by the total
susceptible population over time) increases with age. Health costs for RA patients are
estimated to be about three times that of individuals of the same age and gender who
do not have RA (Pincus, 1995).
Personal costs. RA patients lose more income due to permanent disability
compared to the general population (Pincus, 1995; Semble, 1995; Lorig, Mazonson &
Holman, 1993). Reports indicate up to 60%-70% of RA patients under the age of 65
have had work disability five years after disease onset. There are substantial
differences between the average annual income of RA patients compared to the
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general population. Annual incomes of males with RA are 52% below the average
male population earnings, and incomes of females with RA are about 74% below their
healthy counterparts (Pincus, 1995). Costs related to family stress, as roles shift
according to disability, are often not easily measured. As work disability occurs, roles
change. Male head of households may find themselves unable to work and relying on
outside assistance. Females may find themselves unable to care for their children nor
maintain their household duties. Children and spouses may find themselves spending
up to seven additional hours a week on household duties because of an affected family
member (Samuelsson, Ahlmen, & Sullivan, 1993). Psychological issues, such as
depression and helplessness, arise as the disease creates disabilities (Smith & Wallston,
1992). Efforts need to address the multi-dimensional needs of the RA patient in order
to increase function, decrease symptoms and improve quality of life.
Common Rheumatoid Drug Therapy
The most common therapy for RA is the use of medication for pain alleviation
or disease management (Wolfe, 1996). Although this approach is the current standard
of care, the nature of rheumatoid arthritis is such that destruction of joints and bones
still occurs. Wilske and Yocum (1990) quote a formula used by Dr. Daniel McCarty,
former president of the American Rheumatism Association to describe the impact of
RA: "damage = inflammation x intensity x time." In a passive-observational study, 48
(96%) out of 50 patients being treated with traditional medications showed increased
joint destruction over a 10 year span (Scott, Coulton, & Popert, 1986). Medication
side effects, such as kidney and gastrointestinal complications, as well as

14

polypharmacy issues, remain a constant concern to both patients and doctors (Fries,
1996; Semble, 1995).
The three most common families of drugs for RA will be reviewed: non
steroidal-anti-inflammatory drugs, corticosteroids, and slow-acting-anti-rheumatic drugs
(also known as second-line medications).
Non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs, such as nalproxyn.
relieve pain and swelling in the joints, but are less likely than second-line medications
to prevent damage from the RA disease process (Kwoh, et al., 1996). According to
one cross-sectional study (Segasothy, et al., 1995), the average number of capsules or
tablets of NSAIDs consumed ranged from 1,000-26,300 over a 1 to 30-year period.
This would average approximately three tablets or capsules daily. Though this daily
dosage does not appear extreme, long-term side-effects of NSAIDs can range from
minor discomfort to serious complications leading to death. In an epidemiological
study, Fries (1991) found that gastric mucosal disease related to NSAIDs therapy lead
to 76,000 hospitalizations at a cost of about $380 million dollars a year and 7,600
deaths each year in the United States. Gut permeability is increased by long-term use
of NSAIDs allowing entrance of harmful antigens suspected to pass through epithelial
membranes (Darlington & Ramsey, 1994). Rheumatoid arthritis patients are typically
on NSAIDs for long periods before attempting second-line drugs, such as methotrexate
(Semble, 1995). However, in as little as two years from disease onset, regardless of
NS AID use, rheumatoid arthritis patients develop some form of joint damage and
within 5 to 10 years this damage is debilitating. Though RA symptoms can be
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alleviated with NSAIDs, it is clear that for many patients with RA, medications within
this classification will not be the long-term answer to RA disease management.
Corticosteroids. Up to 80% of patients with RA use corticosteroids, such as
prednisone, to alleviate painful inflammatory responses until other second-line drugs,
such as methotrexate, are initiated (Kwoh, et al., 1996; Saag, Criswell, Sems,
Nettleman, & Kolluri, 1996; Schumacher, 1988; Semble, 1995). Dependent upon
individual response, corticosteroid use is then limited to periodic local application
(joint injections) to alleviate severe flares. A joint can only be injected in the same
location once in a three month period. Daily oral doses of <10 mg of prednisone are
considered relatively safe, where the benefits usually outweigh the risks. Saag and
colleagues (1996), through a meta-analysis of nine studies examining efficacy of
corticosteroid use among RA patients, found corticosteroids may be as effective in
controlling disease outcome measures as second-line drugs, though most studies did
not have radiographic evidence to document disease progression. These findings may
lend justification of prolonged use of corticosteroids prior to introducing second-line
medications. However, some of the side effects of corticosteroids can be serious, such
as development of hypertension, diabetes, atherosclerosis, glaucoma and cataract
formation, osteoporosis, increased susceptibility to infection, and impaired wound
healing (Simms, et al., 1996). Thus, there are high costs associated with corticosteroid
use. In fact, even cessation of long-term prednisone use requires tapering of the
dosage prior to termination. This creates potential complications of treating RA
patients with corticosteroids.
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Slow-acting-anti-rheumatic-drugs (SAARDs). SAARDs, also known as secondline therapy, involve medications that alter the RA disease pattern. Methotrexate is
one of the newer SAARDs approved in 1988 by the Food and Drug Administration. It
has shown good results in disease control and can be used for several years and is
usually only discontinued because of toxicity (Simms, et al., 1996). On rare occasion,
toxicity can result in hepatic fibrosis or cirrhosis (Simms, et al., 1996). Though
myelosuppression is very uncommon in low doses of methotrexate (5-20 mg/week),
complications arising from this condition include sepsis, severe anemia and bleeding.
Methotrexate has been associated with folate depletion and therefore may warrant
adjunct supplementation of this vitamin (Morgan, Baggott, Vaughn, Austin, Veitch,
Lee, et al., 1994).
Currently, there is debate among rheumatologists as to when the introduction of
the SAARDs should be administered. Initial treatment of RA appears to be directed at
symptom alleviation (eg., NSAIDs) as opposed to disease alteration through
medications (eg., methotrexate). Recent research findings indicate, however, early
aggressive treatment with SAARDs, and perhaps combination drug treatment, such as
methotrexate and auranofin, may have more profound effects on RA management, thus
reducing the amount of permanent disability (Harris, 1996; Semble, 1995; Tugwell,
1996). Caution is warranted regarding polypharmacy issues. Tugwell (1996) reports
the incidence of side-effects were higher in RA patients on combination drug treatment
compared to those treated with single drug therapy. Much of RA treatment is
dependent upon the individualized response of each patient. Physicians argue that if
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an individual with a longer duration of disease is presented with second-line drugs,
they are not as responsive as those who have been recently diagnosed (Fries, 1996).
Fries (1996) reports that to strike early in the disease, with individualized multiple
drug combinations, using a "step-down" approach over time, the RA patient will
consume less medication over time, experience the optimal initial benefits of early
intervention and fewer side effects.
Though studies examining relationships between medication use and lifestyle
are lacking, there is sufficient evidence to indicate most RA medications reduce
symptoms and the newer SAARDs control RA disease activity to some degree.
Regardless of effectiveness, long-term use of all RA medications lead to serious
potential side-effects and toxicity issues and thus warrants investigation of adjunct
therapy that may reduce medication need.
Lifestyle Factors and Rheumatoid Arthritis
Rheumatoid arthritis is a chronic disorder. And though the development of
newer medications provide hope for altering the rate or progression of disease
destruction, the chronic use of medication is not without cost. Alternative ways of
reducing symptoms of RA have been investigated. This literature review will provide
recent evidence that indicates certain individual lifestyle factors, such as exercise and
diet, can reduce symptoms of RA.
Effects of exercise on rheumatoid arthritis. Several authors debate the
advisability of exercise for rheumatoid arthritis patients (Lyngberg, Harreby, Bentzen,
Frost, & Danneskiold-Samsoe, 1994; Stenstrom, 1994). There is agreement that
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strenuous exercise should not be performed during severe RA flares, but research
currently indicates that RA patients can enjoy the same health benefits from physical
activity as the general population with minimal risk (Stenstrom, 1994). Since RA is a
chronic progressive disease, bone deterioration is still the likely outcome, but exercise
is no longer believed to contribute additional destruction beyond the normal
pathogenesis. There is also evidence that early introduction of physical rehabilitation
in treatment of RA may decrease the risk of future bone deterioration by increasing
bone density (Shawe, Hesp, Gumpel, Sambrook, & Reeve, 1993). Radiological
evaluation of disease progression in sedentary patients showed decreased bone density
compared to patients with increased physical activity who actually showed an increase
in their bone density (Shawe, et al., 1993).
The following section examines studies that report different types of exercise
which appear to offer some benefits for the RA patient.
Aquatic exercises. Stenstrom (1994) recently examined the progression of joint
destruction in RA patient exercise groups over a period of four years, using radiologic
evaluation for joint destruction. Sixty-nine RA patients self-reported levels of aerobic
exercise. Thirty-five (51%) were randomized and participated in an aquatic highfrequency exercise group (greater than twice a week) that involved intensive training
(eg., exercise designed at intentional muscle motion) in water at the hospital 10 out of
12 months each year for four years. The remaining 34 acted as controls (those
exercising less than once a week) during this 4-year study. Laboratory disease
markers for RA were assessed and included the serum rheumatoid factor (RF) and
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erythrocyte sedimentation rate (ESR). These indices were used to reflect disease
severity and any annual changes over the four years along with annual radiographic
evaluations. Though 90% of all patients showed some radiological deterioration over
the four years, there was no significant difference in levels of destruction comparing
the aquatic high-frequency exercise group (greater than twice a week) to the control
group (those exercising less than once a week).
Other investigators report benefits of aquatic training, such as increased
mobility and muscle strength, and decreased pain (Danneskiold-Samsoe, et ah, 1987).
In their case-control study, significant levels of increased muscle strength occurred at
the end of two months for the trained group (n=8) with no change for the control
group (n=8), who were matched for age and gender and used only for comparative
muscle strength data. Training included pool resistive exercises twice a week for eight
weeks. Though at the end of the 2-month study significant improvements were found,
the 2-month follow-up indicated that without continued exercise, muscle strength
decreased in the trained group, though not to baseline levels.
Stationary cycling. Twenty women with RA were randomly placed into one of
four groups: a control group who were not asked to exercise or one of three exercise
groups of varying duration (15, 23, or 35 minutes) of aerobic (bicycle ergometer)
exercise at 70% of maximal heart rate, 3 times per week for 12 weeks (Harkcom,
Lampman, Banwell, & Castor, 1985). In this pre-test post-test study design, the
lowest level of aerobic time (15 minutes) actually showed the greatest improvement in
RA outcomes compared with baseline values, of increased function and patient global
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assessment (overall assessment of current condition). Virtually all exercise groups,
except the control group reported increased stamina without exacerbating joint
symptoms during the 12-week trial. Though this study neglects to report statistical
differences between groups, and despite the small sample size, these findings could be
important for RA individuals who feel they are limited to shorter episodes of exercise.
RA patients can have fluctuating levels of joint inflammation and pain. Providing
evidence to RA patients that show even short bouts of exercise can help increase
function, could lead to increased likelihood of behavior performance.
Cycling was the aerobic component of another 12-week study where sixtyseven RA patients were randomized into one of four groups in an intervention trial
measuring exercise and RA outcomes (Ekdahl, Andersson, Moritz, & Svensson, 1990).
Two groups were high-intensity training groups, one with 12 scheduled visits, twice
weekly for six weeks; the other was 4 visits, twice the first week, once at week 6 and
once at week 12. High-intensity groups performed multi-disciplined exercises
(calisthenics, stationary cycling, and various resistance exercises) for a combined 60
minutes. A 3-month post-study home routine was designed to include 30 minutes of
daily walking and resistance exercises. The other two groups were low-intensity that
differed from each other by following one of the two distinct visit schedules as the
high-intensity groups. The low-intensity groups performed range-of-motion and
relaxation exercises for a combined 60 minutes. Home routines were also part of the
post-study for the low-intensity groups, which included performing three of the rangeof-motion or relaxation exercises. Significant improvements were found in the high-
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intensity groups for most variables measured, such as increased muscle strength,
endurance and aerobic capacity compared to the low-intensity groups. For both
frequency protocols, subjects in the high-intensity groups were significantly more
flexible (increased mobility) and stronger by the end of the study compared to the
low-intensity groups. Patients in the high-intensity groups subjectively reported
feeling better, stronger and had more stamina than those reported in the low-intensity
groups. Levels of improvement were maintained to some degree during the 3-month
home training phase. RA patients may experience more benefits by following a highintensity exercise program, rather than a low-intensity exercise program.
Walking, swimming and range-of-motion comparison. A 12-week randomized
study examined the training effects of aerobic walking (n=28), pool exercise (n=38) or
the control group, range-of-motion exercises (ROM, n=28) on RA outcomes in patients
with RA or osteoarthritis (Minor, Hewett, Webel, Anderson, & Kay, 1989). Betweengroup analysis showed significant aerobic capacity improvement (p=.009) for the
aerobic groups (walking or pool) compared to the control group (ROM). Within group
analysis showed higher numbers of RA outcome had significant clinical changes in the
aerobic groups at 12-weeks compared to baseline data than did the ROM group. The
pool group increased their aerobic capacity, exercise endurance, grip strength and
trunk flexibility, while improving their heart rate recovery time, AIMS scores, had
fewer tender joints, less morning stiffness and decreased walk time compared to their
baseline levels. The walk group had significant changes in the same variables as the
pool group, except lacked significant changes in joint tenderness or morning stiffness.
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ROM group significantly reduced the number of tender joints, improved flexibility and
AIMS scores from their baseline levels. At the one year follow-up, the between-group
differences were no longer detectible, but there were still significant within-group
differences from baseline for all three groups for most outcome measures. The two
aerobic groups maintained their increased exercise duration from baseline, and
significantly decreased their diastolic and systolic blood pressure readings from
baseline. Additionally, the aerobic groups' tender joint counts were still reduced while
grip strength and joint flexibility were still elevated over time. The control group
(ROM) showed sustained favorable decreases in pain perception and increased
flexibility compared to their baseline levels. Medication changes were not
significantly different between the three groups though most subjects maintained a
stable dose regimen throughout the study, including the 1-year follow-up. Though the
aerobic groups displayed more favorable outcomes, both aerobic and range-of-motion
(ROM) exercises offer the RA patient improved outcomes and should be considered in
combination to maximize benefits.
Strength training. Resistance training is a relatively new area of research for
RA patients. Because of the inflammatory nature of the disease and the involvement
of joints, there are concerns that strength training may exacerbate the disease.
However, recent studies indicate that patients can safely increase muscle tone and
strength through resistance exercises. This is important since many RA patients have
muscle atrophy related to inactivity of various muscle groups (Komatireddy, Leitch,
Celia, Browning, & Minor, 1997; Lynberg, et al., 1994; Rail, Roubenoff, Cannon,
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Abad, Dinarello, & Meydani, 1996). Exercises in three randomized, controlled
intervention studies ranged from simple heel lifts and step-climbing to progressive
resistance training involving the upper and lower body at 80% of one repetition
maximum (RM). Although long-term effects have not been reported, these three 12week trials showed strength training to be a safe form of exercise (by not contributing
to any further destruction of joints compared to controls) for RA patients. Benefits
included increased strength, improved body composition, improved clinical variables,
such as decreased tender and swollen joint count, and night time pain. Also important
is the fact that no negative immune responses nor exercise-related injuries occurred as
direct result of the resistance exercises. Caution is warranted in patients who are
experiencing acute flares; such patients should then keep the resistance levels low.
In summary, there are various forms of exercise, such as swimming, cycling,
ROM, walking and resistance training, that can safely be performed by the RA patient.
Research supports the use of exercise in reducing symptoms of RA. Obviously,
during acute RA flares, patients should limit exercise to range-of-motion activities and
low-impact aerobics such as walking on level ground or swimming for short duration.
However, during non-acute phases, RA patients are limited only by their ability to
perform activities due to their incurred level of physical disability and pain tolerance.
Individuals without major joint damage are capable of physical activities experienced
by the normal healthy population. RA patients can improve their cardiovascular
system, increase muscle strength and flexibility with a sensible exercise program
(Minor, et ah, 1989).
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Dietary Theories and Investigations
Two common theories of how diet affects rheumatoid arthritis are that: 1) food
allergies may manifest some of the symptoms of rheumatoid arthritis; and/or 2) diet
can modify immune or inflammatory responses (Darlington & Ramsey, 1994). This
review will examine the research on diet and RA related to these theories.
Food allergies. Approximately 5-10% of the rheumatoid arthritis population
may have food-induced allergic reactions causing increased disease activity (Panush,
1987; 1990; Kjeldsen-Kragh, et al., 1991). Several case studies or subsets of larger
studies have shown remarkable improvement of clinical variables when avoiding
certain foods, such as eliminating dairy products (Krick, Dietzel, Diehl & Peterson, in
press, 1998; Kjeldsen-Kragh, et al., 1991; Panush, Carter, Katz, Kowsari, Longley, &
Finnic, 1983; Panush, Stroud & Webster, 1986; Parke & Hughes, 1981). Though
improvements found in small subsets or case studies cannot be generalized, the clinical
importance of the improvement for these patients could be a critical key to individual
dietary manipulation for disease remission or at least reduction in symptoms.
A common method for food allergy testing in most studies included a period of
semi-fasting (7 to 10 days) with a diet that contains foods known to be neutral in
allergic responses. It is suggested that the gut permeability in rheumatoid arthritis
patients decreases during fasting, thus reducing the opportunity for food antigens to
cross the barrier to promote inflammatory responses (Rooney, Jenkins, Goodacre &
Sivakumaran, 1983). After a specified period, food challenge begins, or the
reintroduction of food groups begins (Panush, et al., 1986; Kjeldsen-Kragh, et al.,
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1991; Kjeldsen-Kragh, Mellbye, Haugen, Mollnes, Hammer, Sioud, et al., 1994).
Should symptoms, such as increased joint inflammation, become aggravated, the food
is eliminated. If no reaction occurs then the next food group is introduced. Through
this process, foods causing sensitivity or increased RA symptoms can be identified and
eliminated from the diet.
Though RA patients are probably not different than the general population, in
terms of dietary allergic responses, dairy products are most frequently reported as
initiating a dietary allergic response. Other suspected allergens include wheat
products, rice, com, and certain legumes (Beri, Malaviya, Shandilya, & Singh, 1988).
In a single case-study (involving one patient), dairy product consumption, in a
controlled setting, stimulated synovitis (inflammation of the joints) 24-48 hours after
food challenge and resolved 1-3 days after its elimination (Panush, et al., 1986). Upon
re-introduction, symptoms were once again exacerbated. Laboratory findings of
increased milk antibodies confirmed findings of milk sensitivity for this patient. The
exact percentage of RA patients who are allergic to milk and dairy products is
unknown, but warrants further investigation and may be useful for primary caregivers
to consider for clients experiencing unresolved symptoms of RA.
Fatty-acid manipulation. Dietary manipulation of fatty-acid intake does appear
to influence RA disease activity, though precise biological mechanisms still need
further investigation. Certain prostaglandins derived from arachidonic acid lead to
inflammatory responses. However, omega-3 fatty acid series produce fewer
biologically active by-products and have been shown to reduce disease related
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symptoms of rheumatoid arthritis, such as synovitis (Kremer, et al., 1985; Panush,
1987). People who consume diets with increased omega-3 intake, such as fish oils,
report less inflammation and improved health outcomes (Endres, de Caterina, Schmidt,
& Kristensen, 1995). Including sources of omega-3 fatty acids in an otherwise
vegetarian diet, or maintaining a diet that is low in saturated fatty-acids may improve
RA outcomes, including less inflammation. A recent meta-analysis of ten randomizedplacebo-controlled trials showed that using omega-3 containing fish oils had modest
significant improvement on the number of tender joints and duration of morning
stiffness in patients with RA (Fortin, Lew, Liang, Wright, Beckett, Chalmers, et al.,
1995).
The following is an overview of a series of articles where investigators report
on various RA outcomes based on a 13-month randomized-controlled clinical trial
conducted between January of 1987 to October of 1989, that compared the effects of a
vegetarian diet to a control group who followed their normal diet (Kjeldsen-Kragh, et
al., 1991). Fifty-three RA patients were randomized an experimental vegetarian diet
group (n=27) or the control diet group (n=26). Initially, the vegetarian group was
housed for one month at a health resort, while the control group stayed at a
convalescent facility. The vegetarian group followed a liquid-fast for 7-10 days and
went through an elimination and challenge process of foods suspected to aggravate
RA. They proceeded to follow and record a diary of a strict vegan diet (absence of all
animal products), but due to problems of meeting adequate nutritional needs, at the
end of 3-months, this diet was switched to a lactovegetarian (incorporation of dairy
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products). The control group was also asked to maintain a food diary.
At the end of the 4-month stay at the health resort, within group analysis
revealed that the vegetarian group had significantly improved RA outcomes including
reduced number of tender and swollen joints, decreased morning stiffness, and less
pain compared to baseline (Kjeldsen-Kragh, et al., 1991). Decreased pain was the
only significant outcome for the control group at the end of 4 months. Between-group
analysis conducted at the one-year follow-up indicated all RA outcomes were
significantly better for the vegetarian group compared to the control group.
Further analysis of this study was evaluated by Peltonen and colleagues (1994).
They postulated that dietary manipulation alters intestinal flora in some manner,
suggested as reduced intestinal inflammation. Investigators found the fecal flora of the
vegetarian group (n=27) to be significantly different from that of the control group
(n=26). In addition, changes in laboratory variables were examined from the original
study data (Kjeldsen-Kragh, Mellbye, et al., 1994). Examining the vegetarian group
closer, a diet-responder for this study group was defined as one who had substantial
improvement in three of six core parameters, such reduced number of swollen joints,
at each of the last three clinical examinations during the 13-month trial (KjeldsenKragh, Haugen, et al., 1994). These authors found reduced leukocyte counts and
reduction of several inflammatory markers, significantly favored the diet-responders
(n=12) compared to non-diet-responders (n=T5) in the vegetarian group. Though the
fatty acid profile changed significantly for the diet responders, there was no significant
statistical association between the changed profile and RA clinical improvements.
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Unlike studies that examined the effects of dietary supplementation of specific fatty
acids (e.g., omega-3), this study investigated changes in the fatty acid profile as a
result of a 1-year vegetarian diet. The relationship of these fatty-acid changes to RA
outcomes is unclear and remains an area for additional research (Haugen, KjeldsenKragh, Bjerve, Hostmark, & Forre, 1994).
An important issue for many dietary studies was problems with maintenance of
a new diet and/or compliance with extreme changes in dietary regimens, such as
consumption of only raw plant foods, or the elimination of all meat, poultry, and dairy
products (Beri, et al., 1988; Darlington, Ramsey & Mansfield, 1986; Kavanagh,
Workman, Nash, Smith, Hazleman, & Hunter, 1995; Rauma, Nenonen, Helve, &
Hanninen, 1993). As with any treatment, dietary interventions are generally only
effective if the patient can maintain the recommended therapeutic levels, which may
mean the complete abstinence from products previously enjoyed by RA patients.
The experimental vegetarian study by Kjeldsen-Kragh, et al. (1991) did show
significant improvements in the vegetarian group (n=27) over the control group
(n=26), but by the end of the tenth month a total of 10 patients (37%) from the
vegetarian and 9 of the controls (35%) had dropped out of the study, some due to
flares with their arthritis. Unfortunately, the investigators do not indicate the
compliance rate of the vegetarian group "diet responders" (n=12) versus diet "non
responders" (n=15). Though not significant, diet responders had a shorter disease
duration and fewer tested positive for rheumatoid factor (a common serum RA disease
marker) at baseline. This suggests, though not conclusively, that their initial condition
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may not have been as severe as the diet non-responders. Overall, the investigators still
felt the results support their original hypothesis that a vegetarian diet can positively
alter the rheumatic disease outcome in some patients, but they also believe disease
duration and severity may account for much of the variation within the vegetarian
group.
In summary, this current literature provides evidence that diets that involve
abstaining from dairy products, are high in omega-3 sources, or are vegetarian are
associated with improved RA outcomes. However, it is clear that no matter what diet
is recommended, compliance is an important issue when designing a diet for the RA
patient.
Comprehensive Lifestyle Intervention
The combined effect of lifestyle factors on rheumatoid arthritis is lacking in the
literature. In an effort to determine the effectiveness of a comprehensive lifestyle
intervention, Krick, et al. (in press, 1998) report a 98% compliance rate (which is
extremely high compared to commonly reported rates) for completion of a randomized
12-week double-blind controlled experimental trial (n=45). The investigators designed
a multi-dimensional approach to treatment (diet, exercise and stress management) of
RA patients (n=23) and evaluated disease activity compared to a control group (n=22)
who followed a "self-help” approach utilizing the Arthritis Self-Management Leader's
Manual published by the Arthritis Foundation (Lorig, 1984). This book provides
educational information on disease pathogenesis, medication use, commonly asked
questions, and techniques for coping with pain management (e.g., relaxation). Subjects
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in the experimental group were asked to minimize dairy products and maintain a very
low-fat, high-fiber vegetarian diet with no caloric restrictions. The key clinical
variables measured included tender and painful joint count, number of swollen joints,
duration of morning stiffness, physician's global assessment (1-5 scale) and medication
changes at baseline, weeks 4, 8, and 12. Laboratory data consisted of hematologic
evaluations for RA markers including rheumatoid factor (RF), C-reactive protein,
hematocrit and Westergren sedimentation rate (ESR), as well as cholesterol (including
high-density-lipoprotein [HDL]), at baseline, weeks 4, 8 and 12. Additional
assessments included at weeks 4 and 12 were bilateral grip strength, 50-meter walk
time, patient’s global assessment (1-5 scale), a food frequency questionnaire and an
arthritis impact assessment (AIMS2).
Results from this 12-week study (12-week data compared to baseline data)
showed significantly improved RA outcomes in the experimental group over the
control group shown in Tables 2.2-2A Significantly improved disease outcome
measures for the experimental (n=23) over the control group (n=22) included the
number of painful and tender joints and 50-meter walk time (Table 2.2).
Diet was assessed utilizing a food frequency questionnaire (Willett, Sampson,
Stampfer, Rosner, Bain, Witschi, et al., 1985). Dietary changes were in the expected
direction for the experimental group, though the caloric reporting was very low
indicating that patients may have under-reported their caloric intake (Table 2.3).
Weight reduction was significantly lower for the experimental group which may
support the lower caloric reporting; however, under-reporting was likely problematic in
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this study for the experimental group since they were making more changes in their
daily diet intake compared to the control group. Other dietary findings included
significant reductions for cholesterol, animal and vegetable fat, animal protein and
total protein for the experimental compared to the control group.
Table 2.2 Between group comparison of clinical findings from Krick, et al., 1998 study
Intervention Group

Baseline

Week 12

Baseline

Week 12

Between
Group
Differences

Number of
painful and
tender joints

17.0 ± 7.4

16.6 ± 10.4

15.3 ± 5.6

8.8 ± 5.3

p=0.004

50 meter walk
time in
seconds

35.8 ± 9.6

31.9 ±9.8

89.8 ±208.8

75.8 ±212.3

p<0.001

Control Group

Table 2.3 Between group comparison of dietary findings from Krick, et al., 1998 study
Intervention Group

Control Group

Between
Group
Differences

Baseline

12 Weeks

Baseline

12 Weeks

144.4 ± 17.6

158.2 ± 40.3
1974.4 ± 559.7

150.1 ± 40.9
1084.7 ± 371.5

p=0.001

1584.9 ± 497.4

144.1 ± 18.9
1571.1 ± 640.9

Cholesterol
(gms)

183.2 ±76.4

184.5 ± 106.8

239.3 ±81.5

24.8 ± 18.9

p<0.001

Animal fat
(gms)

28.2 ± 13.3

26.7 ± 18.0

37.0 ± 13.2

3.4 ± 2.4

p<0.001

Vegetable
fat (gms)

23.9 ± 12.7

26.2 ± 13.9

34.0 ± 15.2

16.6 ± 8.1

p<0.001

Animal
protein
(gms)

44.5 ± 19.0

44.5 ± 25.0

55.6 ± 20.2

5.7 ± 4.8

p<0.001

Total
protein
(gms)

66.1 ± 23.1

68.1 ± 29.6

81.4 ± 23.3

29.8 ±11.8

p<0.001

Weight (lbs)

Total
calories

p<0.001

Significant laboratory improvements for the experimental group included RFfactor and improved total serum-cholesterol (laboratory data not shown). The change
in HDL favored the control group, and though this change was a significant finding, it
probably was not important because the experimental group had a higher HDL
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baseline level compared to the control group. Further, HDL levels for both groups at
the end of 12-weeks were above 65 mg/dL, indicating satisfactory levels.
Additional significant findings for RA disease outcome measures were
improvements in the self-reported changes in the physical and social components of
AIMS2 and improved health satisfaction for the experimental over the control group
(Table 2.4).
Table 2.4 Between group comparison of AIMS2 findings from Krick, et al., 1998 study
Intervention Group

Baseline

12 Weeks

Baseline

12 Weeks

Between
Group
Differences

Current health
satisfaction

3.1 ± 1.3

3.4 ± 1.3

3.6 ± 1.3

2.4 ± 1.3

p=0.003

Physical
component

2.9 ± 1.8

2.5 ± 1.7

3.5 ± 1.9

2.1 ± 1.8

p=0.004

Social
component

3.9 ± 1.5

3.9 ± 1.6

3.9 ± 1.6

3.0 ± 1.4

p=0.003

Control Group

These findings indicate a brief comprehensive intervention can improve RA
outcomes, including reduced number of painful and tender joints, improved walk time
and improved self-assessments regarding RA disease impact.
The purpose of this research was to conduct a cross-sectional study to test the
strength of association between diet and components of AIMS2 identified as important
in the Krick (1998) study, as well as exercise patterns and self-efficacy, on a larger
sample from the same population group of rheumatoid arthritis patients at the Loma
Linda University Faculty Medical Offices, Department of Rheumatology.
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CHAPTER THREE: DETAILED METHODOLOGY
Study Design
This was a cross-sectional correlation study designed to measure the strength of
association of diet, exercise, self-efficacy, and outcome expectations to rheumatoid
arthritis disease activity. Subjects were asked to complete self-reporting measurements
compiled into a single comprehensive questionnaire and a nutrition pamphlet that
measured frequency of dietary intake.
Setting and Subjects
Subjects were recruited from the waiting room facilities of the Loma Linda
University Faculty Medical Offices, Rheumatology Department from July of 1997 to
January of 1998. Front office staff were oriented with a flow chart (see Appendix A)
to obtain subjects. Due to staff changes and shortages, this method worked for a
limited time but it became necessary for the primary investigator to sit in the waiting
room facilities twice a week to recruit the remainder of subjects.
Inclusion criteria. Prior to inclusion, patients filled out a short screening form
or were verbally screened with the following questions:
1) Do you have rheumatoid arthritis?
2) Have you been diagnosed with rheumatoid arthritis for at least 6 months?
3) Are you between the ages of 18 and 80?
4) Have you been healthy and free from any hospitalization for any serious
illness unrelated to rheumatoid arthritis in the past 6 months?
5) Knowing that your answers will remain confidential, are you willing to
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complete a questionnaire about rheumatoid arthritis which may take up to
one hour?
No record was kept as to how many patients were actually screened, how many
patients declined to participate, nor how many actually qualified. But those
individuals who answered "yes" to all questions were invited to participate in the
study. Average time of completion of the comprehensive questionnaire was
approximately 20 minutes.
Informed consent. This study proposal was presented to and approved by
Loma Linda University Institutional Review Board (Appendix B) who determined the
risk of participation to be minimal. All subjects who agreed to participate signed an
informed consent which outlined the study design, purpose and any potential risks
involved in completing the questionnaire. Confidentiality was guaranteed. Subjects
received a copy of this informed consent along with a cover letter from the primary
investigator (Appendices C and D).
Comprehensive Questionnaire
A single questionnaire was developed (see Appendix E) by combining existing
RA surveys: the Arthritis Impact Measurement Scales (AIMS2) (Meenan, Gertman, &
Mason, 1980; Meenan, Mason, Anderson, Guccione, & Kazis, 1992; Meenan,
Gertman, Mason, & Dunaif, 1982), the Rapid Assessment of Disease Activity in
Rheumatology (RADAR) (Mason, Anderson, Meenan, Haralson, Lewis-Stevens, &
Kaine, et ah, 1992), and a RA self-efficacy scale (Lorig, Chastain, Ung, Shoor, &
Holman, 1989). In addition, items that measured outcome expectations, exercise
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frequency and duration, and RA medication use were developed. The Nutrition
Profile© (Health Awareness Series, 1993) was used to assess dietary intake.
AIMS2. The Arthritis Impact Measurement Scale was developed in the early
1980s and has proven to be a valid and reliable tool in research (Meenan, et ah, 1980).
This tool has twelve subscales with methodological techniques that allow combination
of subscales to form the following components: physical, affect, symptom, social
interaction and social role. The physical and social interaction components of AIMS2
were predetermined as important for this study group based on results from Krick and
colleagues (in press, 1998), so subscales which made up these components were
measured. Also measured was the AIMS2-symptom (pain) component and its
corresponding subscales, felt by current investigators as equally important as an RA
outcome assessment, because literature indicates control of pain is a fundamental to
disease management. The alpha coefficient for the subscales and components in the
current study were similar to those found in Meenan and colleagues (1980) validation
study. Higher AIMS2 component scores indicate a worse condition.
Two additional questions from AIMS2 were included: patient global assessment
("What is your overall assessment of your current condition?"), and overall health
satisfaction ("How satisfied are you with your health now?"). Higher global or health
satisfaction scores represent greater satisfaction with current disease status or current
state of general health.
The assessment of the demographic variables of age, gender, race, marital
status, level of education and income were formatted similarly to how they are
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assessed on the AIMS2 (see Appendix E). Patients were asked to record their height
in inches, which was converted into meters, and weight their weight in inches, which
was converted into kilograms. Their body mass index (BMI) was then calculated
using the Quetelet index formula (Reviki & Israel, 1986). An RA disease duration
variable was also created, with five options: less than one year, 1-3 years, 4-6 years,
7-9 years and greater than 9 years.
RADAR.

This scale measures disease activity and current symptoms, such as

total joint pain. RADAR was developed by some of the same authors as the AIMS2
(Mason, et al., 1992). Together, RADAR and AIMS2 provided a complementary
representation of the RA patient.
The individual subscale alpha coefficients for RADAR in this study (see
Chapter 5, Table 5.4) were similar to those reported by Mason and colleagues (1992).
The three subscales of joint pain, disease activity and functional ability were highly
intercorrelated in the current study with an overall alpha coefficient of .86; therefore,
subscales were combined to represent a single total RADAR score (see Tables 3.1 and
3.2 for details). Higher scores indicated more symptoms of disease activity.
Table 3.1 Calculations for total RADAR score
Variable
RADAR disease activity
Disease activity past 6 months
Disease activity today
Pain today

Formula
SUM(Activity past 6 months, activity today, pain today) - 3

RADAR function ability
Stiffness today
Inabilities today

SUM(Stiffness today, inabilities today) - 2

RADAR joint pain
Right side joint pain
Left side joint pain

SUM(Right side joint pain, left side joint pain) - 2

RADAR TOTAL SCORE

SUM(RADAR disease activity, RADAR ability, RADAR joint pain)
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Table 3.2 Means and standard deviations for RADAR subscales and total RADAR score
Subscale/Scale

n

Means and standard deviations

Range

RADAR disease activity
RADAR function ability
RADAR joint pain

75
75
74

2.1 ± 1.2
1.9 ± 1.1
1.8 ± 1.4

.13-4.50
.50 - 4.50
.00 - 5.80

RADAR TOTAL SCORE

75

5.8 ± 3.2

.63 - 14.30

Self-efficacy and outcome expectation scales. Level of self-efficacy for
controlling RA symptoms was assessed using a previously developed RA self-efficacy
scale (Lorig, et al., 1989). This instrument includes three self-efficacy subscales
measuring perceived confidence in controlling: function (nine items), pain (five items),
and symptoms (six items), which were combined to create a single total self-efficacy
score (ranging from 10-100, with 100 indicating better status). The reliability of these
scales indicated a high degree of consistency with a combined subscales alpha
coefficient of .93 (see Chapter 5, Table 5.4).
Items to assess outcome expectations regarding exercise and diet were
developed using the same rating format as the self-efficacy scale (10-100, with 100
indicating better status). Three questions made up the outcome expectation scale: "As
of now, how certain are you that you can:
1) reduce your symptoms of arthritis by exercise?"
2) reduce your symptoms of arthritis by eating certain foods?"
3) reduce your symptoms of arthritis by avoiding certain foods?"
The first question represented "exercise outcome expectations." The two diet outcome
expectations questions were highly intercorrelated (r=.84), so were combined to
represent the "dietary outcome expectations" construct. Both scales were coded so that
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higher scores indicated more favorable expectations.
Dietary assessment. Food intake was estimated by a short Nutrition Profile©
(Health Awareness Series, 1993). Due to the small study sample size, individual
dietary items could not be evaluated, so a single comprehensive diet score was needed.
Therefore, a scoring system was created to weight individual dietary constructs equally
to allow the combination into a single score. To assure equal weight of each diet
construct, the caloric distribution of macro-nutrients (carbohydrate, protein, and fat),
cholesterol and fiber intake were first compared to goals set for the United States
(U.S. Senate Select Committee on Nutrition and Human Needs, 1990; Shils, Olson, &
Shike, 1994). Each construct was then rated on a 1-5 scale, with "1" indicating the
least desirable diet rating and "5" as the best diet rating. For example, if the reported
fat intake was <70% of the recommended dietary goal of 30% of the total caloric
intake (<21% of total calories) it was rated as a "5" indicating the best rating for fat
intake (see Table 3.3 for details on dietary construct formula). However, if a reported
fat intake level was >130% of recommendations (>39% of total calories) this received
the lowest value of "1," indicating the least desirable fat intake. In addition, three
constructs were developed to examine the frequency of meat, dairy, and fish
consumption which were then rated on a 1-5 scale. All individual construct ratings
were combined to produce a single dietary score (Table 3.3). Higher scores indicated
healthier dietary practices. Eighty-eight percent (n=66) of the 75 subjects completed
the diet questionnaire, though attempts were made to obtain complete data from the
other individuals through additional mailings.
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Table 3.3 Calculations and scoring criteria for dietary variables.
Variable rated
Protein

Comparative value
12.5% of kcal

Percent of comparative daily value and actual range

Rating

75-90% of 12.5% = 9.4-11.2%
90.1-110% of 12.5% = 11.3-13.8%
110.1-120% of 12.5% = 13.9-15%
120.1-130% of 12.5% = 15.1-16.2%
>130% or <75% of 12.5% = > 16.3 or <9.3%

of
of
of
of
of

kcal
kcal
kcal
kcal
kcal

5
4
3
2

1

Carbohydrates

58% of kcal

>110% of 58% = >63.8%
90.1-110% of 58% = 52.3-63.8%
80.1-90% of 58% = 46.5-52.3%
70-80% of 58% = 40.6-46.4%
<70% of 58% = <40.6%

of
of
of
of
of

kcal
kcal
kcal
kcal
kcal

5
4
3
2

Fat

30% of kcal

<70% of 30% = <21%
70-90% of 30% = 21-27%
90.1-110% of 30% = 27.1-33%
110.1-130% of 30% = 33.1-39%
>130% of 30% = >39%

of
of
of
of
of

kcal
kcal
kcal
kcal
kcal

5
4
3
2

Saturated fat

10% of kcal

<70% of 10% = <7%
70-90% of 10% = 7-9%
90.1-110% of 10% = 9.1-11%
110.1-130% of 10% = 11.1 -13%
>130% of 10% = >13%

of
of
of
of
of

kcal
kcal
kcal
kcal
kcal

5
4
3
2

mg/dL
mg/dL
mg/dL
mg/dL
mg/dL

5
4
3
2

Cholesterol

Fiber

Variable rated
Dairy rating
Non-fat
Low-fat
High-fat

<70% of 300 mg/dL = <210
70-90% of 300 mg/dL = 210-270
90.1-110% of 300 mg/dL = 270.1-330
110.1-130% of 300 mg/dL = 330.1-390
>130% of 300 mg/dL = >390

300 mg/dL

>110% of 28 gms = >30.8
90.1-110% of 28 gms = 25.3-30.8
80.1-90% of 28 gms = 22.5-25.2
70-80% of 28 gms = 19.6-22.4
<70% of 28 gms = <19.6

28 gms

Weighted servings/week

Scoring criteria
SUM(# of non-fat servings/week x .5),
(# of low-fat servings/week x 1.5), &
(# of high-fat servings/week x 3)

Meat rating
Low-fat
Medium-fat
High-fat

SUM(# of low-fat servings/week x .5),
(# of medium-fat servings/week 1.5), &
(# of high-fat servings/week x 3)

Fish rating

# of servings/week

Total Dietary
Score =

gms
gms
gms
gms
gms

1

1

1

1
5
4
3
2

1
Rating

0-2
2.1-4
4.1-6
6.1 - 8
>8

servings
servings
servings
servings
servings

5
4
3
2

0- 1
1.1-2
2.1 - 3
3.1 - 4
>4

servings
servings
servings
servings
servings

5
4
3
2

>4
3.1-4
2.1-3
1.1-2
0- 1

servings
servings
servings
servings
servings

5
4
3
2

1

1

1

SUM (protein rating, carbohydrate rating, fat rating, saturated fat rating, cholesterol
rating, fiber rating, meat rating, dairy rating, and fish rating).
Actual range = (11-39), possible high = 45.
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Additional dietary details can be found in Chapter 5, Tables 5.7 and 5.8.
Exercise. Patients self-reported type, frequency and duration of current
exercise patterns in a form that categorized exercise into three classes: stretching,
aerobic exercise, and strength training (see Appendix E). Exercise frequency was
coded on a 1-5 scale where "1" equalled no exercise and "5" equalled 7 times per
week (refer to Table 3.4 for details). Exercise duration was calculated by summing
the minutes per week from each category, then dividing by seven to give an average
daily exercise duration in minutes.
Table 3.4. Recode information on exercise variables.
Recoded score

Original response score
Frequency:

Duration:

1
2
3
4
5

=
=
=
=
=

(none)
(1-2 times weekly)
(3-4 times weekly)
(5-6 times weekly)
(daily)

0

1
2
3
4
5

=
=
=
=
=

(none)
(1-15 minutes)
(15-30 minutes)
(31-45 minutes)
(at least 46-60 minutes)

1.5
3.5
5.5
7
0
7.5
22.5
38
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Frequency and duration ratings were then multiplied to create an overall
exercise score where higher values indicate more exercise (refer to Tables 3.5). Due
Table 3.5. Exercise score formula.
Exercise Score1 =
Step #1:

Highest weekly frequency per category (aerobic, strength, stretching) x sum
(duration of each event in minutes per category) = category scores in minutes
per week

Step #2:

Sum of category scores (aerobic, strength, stretching) + 7 (to represent daily
exercise values)

Step #3:

Daily exercise value x highest original frequency rating = exercise score
(squared for log transformation)

Log transformation of exercise scores were necessary.
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to a few outliers, log transformations were necessary. This was accomplished by
taking the square root of the final exercise scores.
RA medication use. Type, frequency and dosage of RA medication was selfreported in a form designed for this study that separated medications into five
categories: aspirin, non-steroidal-anti-inflammatory-drugs (NSAIDs), steroids, slowacting-anti-rheumatic-drugs (SAARDs), and analgesics (see Appendix E). Due to the
incomplete dosage amounts reported by subjects, medication use was coded simply as
the frequency of doses taken per week, first by classification and then combined for a
single weekly medication frequency variable.
Data Collection
Of the 117 questionnaires distributed over a six month period, 64% (n=75)
were completed and returned. While patients were encouraged to complete the
questionnaire in the waiting room facilities, guaranteed postage was provided to those
who preferred to complete the survey at home. Forty-two (52%) of the 81 patients
who chose to complete the questionnaires at home did not return the surveys. All
qualified subjects received a small token of appreciation regardless of their final
decision to participate. RA-related tokens included one or more of the following:
letter openers, pencil pillows, and/or jar openers.
Data Analysis
Statistics were performed using computerized SPSS, PC Network Version 7.0
for Windows (Copyright© SPSS Inc., 1989-1995). Descriptives, frequencies and
distributions were performed for all variables prior to manipulation of the data.
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Power analysis. The power analysis was determined from the original intent to
measure two variables, diet and exercise, to symptoms of RA. Sixty-seven patients
were needed for a medium-effect size with the significance criterion alpha at .05 with
power of .80 (Cohen, 1992) for regression analysis.
Reliability scales. Reliability analysis was determined for questions
contributing to each measured subscale to verify internal consistency. Individual
questions that did not meet a reliability coefficient alpha of at least .50 were excluded
from its respective subscale and evaluated separately. Except for the three items in
the total outcome expectations scale, all others displayed strong internal reliability with
coefficient alphas all greater than .80 (see Chapter 5, Table 5.4).
Preliminary correlations. Pearson correlations were computed to determine
entry of predictor and outcome variables for multiple regression analysis. Key
outcome measures that correlated well with disease status (or symptoms) were the
symptom component of AIMS2 (which measures pain) and the comprehensive
RADAR score (which measures disease activity). Health satisfaction was also highly
intercorrelated with disease status, indicating lower satisfaction as disease activity (r=
-.52) and pain increased (r=-.54; see Table 3.6). Although patient global assessment
(which measures patient satisfaction with current condition) was correlated with two of
the three outcome measures (health satisfaction [r=.35] and disease activity [r—.28]),
the values were not as strong and so this variable was dropped from further analysis.
Predictor variables included diet, exercise, self-efficacy, diet and exercise
outcome expectations and medication dosage. Except for diet and exercise, predictor
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variables correlated with at least one of these outcome measures (n=75; see Table 3.6).
Correlations among exercisers only (n=57) are shown in Table 3.7.
Linear regression analysis. The regression analysis requires that all variables
entered into the model be present for inclusion, so missing data forced cases to be
dropped, automatically excluding individuals who did not complete the dietary
questionnaire. After demographic variables were entered into regression analysis, 60
subjects (80% of all subjects) formed the inclusive group and 43 subjects (75% of all
exercisers) formed the exercise only group.
Regression analysis was performed first on "all subjects" (n=60) and then on
"exercisers only" (n=43) because of the unique pattern of associations among those
who exercised and because they unexpectedly differed in their patterns of associations
of outcome expectations. Demographics (age, gender, race, marital status, education,
annual income, disease duration, and BMI) were simultaneously entered as a single
block into the multiple regression followed by the stepwise regression of the selected
predictor variables. Predictor variables were initially entered simultaneously as a
single block; however, "stepwise" regression analysis was ultimately used because of
the small number of predictor variables and the lack of correlation among these
predictor variables (Thompson, 1995). Results were virtually identical with either
method (see Chapter 5, Table 5.5).
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Table 3.6 Correlation matrix for predictor variables and outcome measures for all subjects (n=75)

Diet Rating
Exercise Rating
Rx Frequency
Self-Efficacy
Diet Outcome Expectations
Exercise Outcome Expectations
AIMS2-Pain
RADAR
Health Satisfaction

Exercise
Rating

Rx
Frequency

-.10

.04
.04

SelfEfficacy
.07
.12
-.44*

Diet
Outcome
Expectations
.09
-.09
-.08
.26*

Exercise
Outcome
Expectations
.14
.17
-.13
.45*
•47*

AIMS2
Pain
12
-.00
.44t
-.72*
-.19
-.40*

RADAR
.02
12
,36t
-.78*
16
-.32*
.80*

Health
Satisfaction
.26*
-.02
-.28*
.58*
-.01
.29*
-.54*
-.52*

Patient
Global
Assessment
.02
.02
-.28*
•42*
.07
.10
.22
-.28*
.35*

* Correlation is significant at the < .05 level (2-tailed).
t Correlation is significant at the < .01 level (2-tailed).
t Correlation is significant at the < .001 level (2-tailed) - adjusted for Bonferroni.
Shaded area indicates outcome variable intercorrelations.
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Table 3.7 Correlation matrix for predictor variables and outcome measures for exercisers only (n=57)

Diet Rating
Exercise Rating
Rx Frequency
Self-Efficacy
Diet Outcome Expectations

Exercise
Rating

Rx
Frequency

.07

.06
-.13

SelfEfficacy
.13
.22
-.49*

Diet
Outcome
Expectations

Exercise
Outcome
Expectations

.11
-.15

.17
.24

16

-.22

.26

AIMS2
Pain
.09
-.22

RADAR
-.03
.25

Health
Satisfaction

Patient
Global
Assessment

.19
.13

.00
.11
-.30*

41*

.36*

-.32*

•52*

-.72*

-.78*

.65*

.38*

-.27*

-.18

.03

-.50*

-.38*

.42*

.79*

-.57*

14

-.59*

-.20

Exercise Outcome Expectations
AIMS2-Pain
RADAR
Health Satisfaction

* Correlation is significant at the < .05 level (2-tailed).
t Correlation is significant at the < .01 level (2-tailed).
$ Correlation is significant at the < .001 level (2-tailed) - adjusted for Bonferroni.
Shaded area indicates outcome variable intercorrelations.

.36*
-.01
.07

.32*

Chapter Four: "Are Lifestyle Factors Related to
Symptoms of Rheumatoid Arthritis?"
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Benefits to Rheumatology
Our study suggests that rheumatoid arthritis (RA) patients with higher
perceived control over RA symptoms and who practice a lifestyle that includes a
healthy diet and/or regular exercise, show fewer symptoms of RA and greater health
satisfaction. Though causal conclusions cannot be drawn from a cross-sectional study,
rheumatologists may find promoting healthier lifestyles for their patients beneficial as
adjunct therapy. Additionally, techniques to enhance the confidence of RA patients to
improve their diet and exercise can be applied to help them achieve personal,
attainable goals in improving their RA disease.
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Abstract
Objective. This cross-sectional study examined the relationship of lifestyle
factors to symptoms of rheumatoid arthritis (RA).
Methods. Seventy-five RA patients completed self-assessment surveys
measuring symptoms of RA and lifestyle (diet and exercise), RA medication use, selfefficacy and outcome expectations.
Results. High self-efficacy was associated with significantly less pain (AIMS2adjusted R2=.48, p=.000003) and less disease activity (RADAR- adjusted R2=.59,
p=.000000004). High self-efficacy and a healthy diet were associated with
significantly greater health satisfaction (adjusted R2=.31, p^.001). Additionally, among
only those who exercised (n=43), those who had higher self-efficacy and exercised
more frequently had significantly less pain (AIMS2- adjusted R^.bO, p=.00002).
Conclusions. Results suggest that RA patients with greater self-efficacy in
controlling their disease, and who follow a healthy diet and exercise, report fewer
symptoms of RA.
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Rheumatoid arthritis (RA) is a chronic, destructive, inflammatory autoimmune
disease that affects approximately .5-2% of the adult population over 18 years of age
(1-3). Females are afflicted with this disease two to three times more often than
males, and Caucasians appear to be affected more frequently than other ethnic groups.
Fries (4) estimates that a typical patient with rheumatoid arthritis will visit their doctor
200 times over the average 25 year span for disease management. Chronic rheumatoid
arthritis leads to erosion of bones most frequently in the wrists, hands and feet, but
often involves other synovial joints (3,5,6). Physical disability is the typical end result
of chronic RA (2). Patients experience severe pain at various stages of the disease,
and long-term use of medications can lead to complications in many cases, such as
chronic nephrotoxicity or gastritis (3,7-13).
Non-medicinal treatment modalities for RA have been studied and found to
reduce symptoms of RA (14,15). Some studies show development of coping skills
beneficial in disease management, especially related to pain control (16,17).
Elimination of certain dietary components, such as dairy products, high-fat foods or
the inclusion of omega-3 fatty acid foods or supplements may reduce the inflammatory
disease process (18-20). Exercise, such as low-impact aerobics, swimming or rangeof-motion exercises can enhance overall health and improve mobility during non-acute
periods without increasing disease activity (21-23).
A multi-disciplinary approach to helping patients with RA has been primarily
through patient education (14,24). There remains a need to examine the relationship
between a patient's lifestyle and RA disease activity in order to establish adjunct
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therapy in treatment of rheumatoid arthritis.
The purpose of this study was to determine the degree of association between
the lifestyle factors of diet and exercise and the symptoms of rheumatoid arthritis. It
was hypothesized that those individuals who followed a healthier diet and regularly
exercised would have fewer symptoms of RA. Further, it was expected that these
individuals would have a higher degree of self-efficacy in controlling their RA and
experience fewer RA symptoms due to their lifestyle.
Methods and Materials
Study Design
This was a cross-sectional correlation study designed to measure the association
of diet, exercise, self-efficacy, and outcome expectations to rheumatoid arthritis
disease activity by the completion of various self-reporting measurements. These
measurements were compiled into a single, comprehensive questionnaire and a
nutrition pamphlet that measured food frequency.
Subjects. Subjects were selected from patients in the waiting room visiting the
Rheumatology Department of the Loma Linda University Faculty Medical Offices over
a six-month period, from July of 1997 to January of 1998. Prior to inclusion, patients
filled out a short screening form or were verbally screened with the following
questions:
1)

Do you have rheumatoid arthritis?

2)

Have you been diagnosed with rheumatoid arthritis for at least 6 months?

3)

Are you between the ages of 18 and 80?
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4)

Have you been healthy and free from any hospitalization for any serious
illness unrelated to rheumatoid arthritis in the past 6 months?

5)

Knowing that your answers will remain confidential, are you willing to
complete a questionnaire about rheumatoid arthritis which may take up to
one hour?

Those individuals who answered "yes" to all questions were invited to participate in
the study. Average time to complete the comprehensive questionnaire was
approximately 20 minutes.
Of the 117 questionnaires distributed, 64% (n=75) were completed and
returned. Those patients participating signed an informed consent. While patients
were encouraged to complete the questionnaire in the waiting room facilities,
guaranteed postage was provided to the 81 patients who preferred to complete the
survey at home. Forty-two (52%) of those patients who chose to complete the
questionnaires at home did not return the surveys. All qualified subjects received a
small token of appreciation regardless of their decision to participate.
Demographic variables. Demographic variables included age, gender, race,
marital status, level of education and income (see Table 4.1). Height was converted
into meters and weight into kilograms, and using the Quetelet index (25), body mass
index (BMI) was then calculated. Disease duration was classified into one of five
categories: less than one year, 1-3 years, 4-6 years, 7-9 years and greater than 9 years.
Disease and symptoms. Current disease activity and impact of RA were
measured utilizing self-reporting questionnaires: the Rapid Assessment of Disease
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Activity in Rheumatology (RADAR) (26,27) and the physical, symptom and social
interaction components of the Arthritis Impact Measurement Scales (AIMS2) (28,29).
Patient global assessment ("What is your overall assessment of your current
condition?") and overall health satisfaction ("How satisfied are you with your health
now?") from AIMS2 were also measured. The RADAR subscales of joint pain,
disease activity and disease ability were highly intercorrelated with an alpha
coefficient of .86; therefore, the three subscales were combined into a single total
RADAR score.
Self-efficacy. Level of self-efficacy was assessed using a RA self-efficacy
scale (30). The tool included three self-efficacy subscales: function, pain, and
symptoms, which were combined to create a single total self-efficacy score ranging
from 10-100, with 100 indicating better status. The internal reliability of the final
scale was very high, with an alpha coefficient of .84 across the combined subscales.
Outcome expectations. An outcome expectations scale was developed using
the same rating format as the self-efficacy scale, ranging from 10-100. Three
questions made up this scale: "As of now, how certain are you that you can:
i)

reduce your symptoms of arthritis by exercise?

2)

reduce your symptoms of arthritis by eating certain foods?

3)

reduce your symptoms of arthritis by avoiding certain foods?"

The first question represented the exercise outcome expectation. The two diet
outcome expectations questions were highly correlated (r=.92), so they were combined
to represent the dietary outcome expectation construct.
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Dietary assessment. Food intake was estimated by a short Nutrition Profile
questionnaire by Wellsource® Inc. (31). Due to the small study sample size,
individual dietary items could not be evaluated in data analysis, so a single
comprehensive diet score was needed. Therefore, a scoring system was created to
weight individual dietary constructs equally to allow the combination into a single
score. To assure equal weight of each diet construct, the caloric distribution of macro
nutrients (carbohydrate, protein, and fat), cholesterol and fiber intake were first
compared to goals set for the United States (32). Each construct was then rated on a
1-5 scale.

For example, if the reported fat intake was <70% of the recommended

dietary goal of 30% total caloric intake (<21% of total calories) it was rated as a "5"
indicating the best rating for fat intake. However, if a reported fat intake level was
>130% of recommendations (>39% of total calories) this received the lowest value of
"1," indicating the least desirable fat intake. In addition, three constructs were
developed to examine the frequency of meat, dairy, and fish consumption which were
then rated on a 1-5 scale. All individual construct ratings were combined to produce a
single dietary score. Higher scores indicated healthier dietary practices (possible range
5-45, actual range 11-39). Eighty-eight percent (n=66) of the 75 subjects completed
the diet questionnaire, though attempts were made to obtain complete data from the
other individuals through additional mailings.
Exercise. Patients self-reported type, frequency and duration of current
exercise patterns in a form that categorized exercise into three classes: stretching,
aerobic exercise, and strength training. Exercise duration was calculated by summing
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the minutes per week from each category, multiplied by frequency, then divided by
seven to give an average daily exercise duration in minutes. Exercise frequency was
coded on a 5-point scale where "1" equalled no exercise to "5" which equalled daily
exercise. Daily duration and the frequency rating were multiplied to create an overall
exercise score where higher values indicate more exercise. Log transformations were
necessary for the final exercise score to correct for non-normal distribution (values
ranged from 0-28.2).
Medication use. Type, frequency and dosage of RA medication was selfreported on a form designed for this study that separated medications into five
categories: aspirin, non-steroidal-anti-inflammatory-drugs (NSAIDs), steroids, slowacting-anti-rheumatic-drugs (SAARDs), and analgesics. Due to the incomplete dosage
amounts reported, medication use was only coded as frequency of doses taken per
week, first by classification and then a cumulative score was calculated for a single
medication frequency variable (values ranged from 0-92 weekly doses).
Data Analysis
Statistics were performed using computerized SPSS, PC Network Version 7.0
for Windows (Copyright© SPSS Inc., 1989-1995). Descriptives, frequencies and
distributions were performed for all variables. Reliability analyses were run for
subscales to verify internal consistency of scales. Individual questions that did not
meet a reliability coefficient alpha of at least .5 were excluded from the subscale and
evaluated separately. Except for the total outcome expectations scale, all others
displayed very strong inter-reliability with coefficient alphas greater than .8.
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Correlations. Pearson correlations were computed to determine entry for
multiple regression analysis. Key outcome measures were the symptom component of
AIMS2 (which measures pain), the comprehensive RADAR score, overall health
satisfaction and patient global assessment. All outcome measures except global
assessment were found to be highly intercorrelated as shown in Table 4.2. Predictor
variables that initially correlated with at least one of these outcome measures were
medication dosage, self-efficacy total score, diet outcome expectations and exercise
outcome expectations. Diet and exercise scores were also included as predictor
variables.
Regression analysis. Regression analysis requires all variables entered into the
model be present for inclusion, so missing data forced cases to be dropped,
automatically excluding the individuals who did not complete the dietary
questionnaire. Sixty subjects (80% of all subjects) for the inclusive group and 43 for
the exercise only group (75% of all exercisers) remained after demographics were
entered into regression analysis. Regression analysis was performed first on "all
subjects" (n=60) and then on "exercisers only" (n=43; 72% of the inclusive group)
because of the unique pattern of associations among those who exercised and because
exercisers were unexpectedly similar to non-exercisers in their patterns of outcome
expectations. Demographics (age, gender, race, marital status, education, annual
income, disease duration, and BMI) were entered simultaneously as a single block into
the multiple regression, followed by the stepwise regression of the selected predictor
variables.
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Results
Patient Characteristics
Seventy-five patients completed the comprehensive surveys. This was a
predominantly Caucasian (72%), female (77%) population with a mean age of 55.5
years (SD±14.3; see Table 4.1). Most patients were married (63%) and were well
educated, with 45% completing at least some college. Though the distribution of
income was fairly even, 49% had an annual income of at least $40,000. Sixty-four
percent of the patients were diagnosed with RA for greater than 9 years. Although
70% of this study sample described their current disease condition (patient global
assessment) as either poor or fair, only 35% reported that they were either very or
somewhat dissatisfied with their overall health (health satisfaction). Mean BMI was
26.3 (SD±5.5). Forty-one percent were actually within their desirable weight, but 51%
were categorized to some degree of obesity. Only two subjects (3%) were classified
as grade 3 obesity level, while 8% were under their desirable weight (31).
Despite the high number of subjects with disease duration greater than nine
years (64%), this was a fairly active group. Though 24% of the subjects (n=18) did
not perform any exercise, most subjects were doing some form of exercise (n=57), and
the majority were exercising daily (74% of all exercisers). Walking was the most
reported form of exercise (77% of exercisers, n=42), averaging approximately 22
minutes per session. Sixty-five percent (n=37) were performing range-of-motion
exercises.
Dietary indications suggest this study sample, on the average, was fairly health
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conscious. While only 8% reported no meat consumption, 24% ate a low intake of
less than 3 ounces per week. Mean weekly dairy servings were 9.7 (SD±9.2). The
average percent of calories derived from fat was 30% (SD±6.7), with 9% (SD±3.1) of
calories coming from saturated fat. Fish consumption was generally low with a mean
of 1.1 (SD±1.4) servings per week.
Significant Findings
All subjects (n=60T Pearson correlation analysis (see Table 4.2) indicated selfefficacy was strongly correlated with most of the RA outcome measures. After
controlling for demographics, regression analysis showed, as anticipated, higher selfefficacy was strongly associated with less pain (AIMS2; F[l,60]6.06, adjusted R2=.43,
p=.00001) and less disease activity (RADAR; F[l,60] 10.69, adjusted R2=.59,
p=.000000004) (see Table 4.3 and Figure 4.1). After controlling for self-efficacy,
improved diet scores accounted for 5% of the adjusted R2=36% for greater health
satisfaction (p=.0002).
Given that self-efficacy was the best predictor of RA outcomes, it was
considered as a possible mediator between the excluded predictors - exercise score,
diet and exercise outcome expectations and medication use - and outcome measures AIMS2, RADAR and health satisfaction. Self-efficacy was then regressed on these
predictors. Results showed that patients who consumed fewer doses of RA
medication, and who held a stronger belief exercise would improve RA symptoms
(outcome expectations), had higher self-efficacy (Table 4.4 and Figure 4.2).
Exercisers only (n=43). For "exercisers only," self-efficacy was also the
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prominent predictor for improved outcome measures (see Table 4.3). High selfefficacy and increased amounts of exercise were associated with significantly less pain
(AIMS2 - adjusted R2=.44, p=.001). Better RADAR scores were also found among
exercisers with high self-efficacy (adjusted R2=.49, p=.0001). Exercisers with high
self-efficacy and exercise outcome expectations, and for undetermined reasons, low
diet outcome expectations, reported greater health satisfaction (F[l,43]5.51, adjusted
R2=.54, p=.0001).
When self-efficacy was regressed upon excluded predictors from the primary
model of explanation, those consuming low-frequency doses of RA medication had
higher self-efficacy, which was related to fewer symptoms of RA (Table 4.4 and
Figure 4.2).
Discussion
The results of this study support the concept that lifestyle factors are related to
symptoms of RA. Patients who reported more favorable lifestyles (healthy diets and
regular exercise) experienced fewer RA symptoms and had greater health satisfaction
than those who led less healthy lifestyles. These patients who followed healthier
lifestyles had a stronger belief they could control their RA symptoms. Among
exercisers, those with high self-efficacy and who held a strong belief that exercise
reduces symptoms of RA, were more satisfied with their health.
Self-Efficacy
This study showed that RA patients with higher self-efficacy for controlling
their disease reported less pain and disease activity (AIMS2 and RADAR) and were
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more satisfied with their overall health. Though this was a cross-sectional study and
no inferences can be made to causality, it is possible that higher self-efficacy leads to
improved outcomes. This is supported by several studies that document fewer
symptoms related to rheumatoid arthritis, such as pain and depression, when patients
had better stress management skills and higher self-efficacy in coping with RA
(16,24,33,34). In addition, when patients perceive greater control over their disease, as
reflected in their self-efficacy scores, their pain scale scores remain lower and patients
report healthier lifestyles despite additional physical disability (15). Self-efficacy
levels related to specific behaviors, such as diet and exercise, should be evaluated
prior to implementing lifestyle changes in RA patients to determine which self-efficacy
skills need to be enhanced to facilitate positive outcomes.
Diet
Patients' current dietary intake was examined to determine if those following a
diet similar to United States dietary goals (32), such as limiting fat intake to 30% of
the total calories, who also consumed fewer meat and dairy servings, and more
servings of fish, were related to fewer RA symptoms. Regression analysis indicated
that RA patients who came closer to these recommended goals (a higher quality diet in
this study was indicated by higher diet scores), reported significantly less pain.
Even after controlling for self-efficacy and demographics, highly significant
findings were found with healthier dietary patterns and RA outcomes, even with our
small sample size. A limitation of this sample size, however, is the determination of
any single dietary construct, such as use of dairy products, as most responsible for this
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significant association with less pain. A larger sample would be necessary to
investigate specific dietary influence on RA outcomes. Yet this study suggests the
patient eating pattern (combined rated constructs), rather than any specific dietary
element, may be most important in predicting RA outcomes.
Dietary outcome expectation (the belief that diet would improve their RA
outcome) was not an independent predictor of dietary behaviors or RA outcomes, even
though there was evidence to suggest that diet was associated with improved RA
status (Figures 4.1 and 4.2). In fact, those exercisers with less confidence that diet
would reduce symptoms of RA were more satisfied with their health. It is unclear
why this might be the case. Perhaps patients had tried special diet patterns which
resulted in no improvement. A controlled-randomized vegetarian trial (35) involving
RA patients found those who believed unconventional treatments would work,
including diet, reported fewer symptoms of RA. Though not supported in our current
study, it is still conceivable that higher diet outcome expectations could improve
adherence to dietary recommendations and thus increase self-efficacy through repeated
performance, leading to reduced symptoms and higher health satisfaction.
Exercise
Overall, 76% of the subjects engaged in some form of physical activity.
Among exercisers, those who exercised more had significantly less pain (AIMS2). For
all subjects, higher exercise outcome expectations in controlling disease were related
to higher self-efficacy scores, which in turn were significantly related to fewer RA
symptoms (see Table 4.3; Figure 4.1). This was interesting because even those who
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did not exercise believed that including exercise in their lifestyle would lead to the
desired outcome of less pain and/or disease activity and improved health satisfaction.
Non-exercisers with high exercise outcome expectations may have incurred permanent
disability limiting their ability to exercise. Though there was no significant difference
in mobility scores (AIMS2) it is important to identify individuals with limitations.
Building on RA patient outcome expectations, a careful assessment of functional
capacity would allow health professionals to recommend specific forms of physical
activity matching individual ability, thus improving general health and perhaps
improving RA disease outcomes.
Various forms of exercise improve RA disease status or results in no further
joint destruction than would have occurred in the normal course of RA disease (36).
Our study showed patients engaged in walking more than any other form of exercise,
which would be considered a safe way of enhancing health. Eighty-five percent of all
subjects did not report any strength (resistance) training, although there is evidence
that during non-acute stages, strength training prevents muscle wasting and is
associated with increased mobility and decreased pain (37-39). Some subjects reported
swimming (n=9; 16% of exercisers) as part of their regular exercise routine. Aquatic
training during non-acute stages of disease has been shown to increase the level of
mobility and patients can function more effectively in their daily activities due to
improved muscle strength (22,23). Nine patients (16% of exercisers) used a motion or
stationary bike for exercise. In previous research, increases in daily function and
patient global assessments (a patient's overall assessment of their current condition)
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have been found in patients who engaged in stationary cycling at low-intensity levels
(40). There is also evidence that initiation of physical rehabilitation at the time of
disease diagnosis decreases the risk of future bone deterioration (41).
The RA patient differs from the general population in that during acute stages
exercise should be limited to range-of-motion activities and low-impact aerobics of
short duration. However, during non-acute phases, RA patients are limited only by
their ability to perform activities due to their incurred level of physical disability.
Those individuals without major joint damage are capable of physical activities similar
to the normal healthy population. Exercise in this study was associated with
significantly less pain (AIMS2), which indicates that this method of alleviating RA
symptoms may be appropriate for RA patients.
Medications
This research showed no direct relationship between diet, exercise and the
frequency of medication taken. However, when medication use was examined by
those consuming high- compared to low-frequency daily doses (>5 doses/day [n=T0]
compared to 0-1 dose/day [n=24]), individuals with higher frequency of daily RA
medication doses had significantly lower self-efficacy scores (M and SD 47.9±16.0
compared to 73.5±17.6; t=4.0, p=.0004). This indicates that perhaps patients
consuming greater frequency of doses did not believe that they were capable of
controlling their RA symptoms using any modality. Patients consuming more
medication had significantly more pain (M and SD 2.2±2.2 doses/day compared to
5.0±1.4 doses/day; t=-3.7, p=.001) and more disease activity (M and SD 4.4±7.4; t=
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-2.5, p=.02). They also indicated less satisfactory levels of mobility than those
consuming less medication (M and SD 1.0±1.4 compared to 4.6±2.9; t=-4.8,
p=.00003). It appears that higher frequency of medication use is related to more
symptoms of RA and perhaps adjunct therapy may be beneficial for these patients.
Disease duration was controlled for in the regression analysis; in fact, combined
demographics had virtually no influence on medication frequency (adjusted R2=-.06).
Medication frequency was not assessed as an outcome measure, but was considered an
independent predictor of RA symptoms. Because of this, we did not expect to see a
direct relationship of medication use to diet and exercise. And though healthier
lifestyles appear to be associated with fewer symptoms and higher health satisfaction,
there was no significant difference in the diet and exercise scores between low and
high frequency of RA medication use.
Since medication rating entailed reporting the frequency of RA medication per
week, there were obvious limits of sensitivity to prescribed doses related to specific
drug classifications. It may be argued that one of the current most effective RA
medications, methotrexate, requires the fewest doses per week (12). These individuals
would therefore have reported the lowest number of medication doses in this study.
However, when selecting cases for regression analysis that only included patients on
methotrexate (83% of all patients), higher frequencies of medication use were still
associated with lower self-efficacy scores (n=62, combined adjusted R2=.39 with
exercise outcome expectations, p^.OOOl), indicating individuals on methotrexate were
taking multiple drugs for treating their RA. Though not significantly different (p=.6),

64

means and standard deviations for number of doses of medications per week (n=62; M
and SD 19.3±17.6) were actually higher for those taking methotrexate compared to
those who were not (n=13; M and SD 16.5±15.6). This highlights the complexity of
treating RA: that there is currently no single medication able to control all symptoms
of RA for most patients. Nearly all of the patients (n^b?; 89%) reported using
multiple classes of medications for RA therapy. Self-efficacy enhancement techniques,
especially for diet and exercise, as adjunct therapy, should be explored for patients
who appear to be non-responsive to drug therapy.
The most common method of pain alleviation or disease management of
rheumatoid arthritis is drug therapy (1,3,7,8,11,12). Although this approach is the
current standard of care, the nature of rheumatoid arthritis is such that destruction of
joints and bones still occurs. In a passive-observational study, 48 out of 50 patients
being treated with traditional medications showed increased joint destruction over a 10
year span (6). Medication side effects, such as kidney and gastrointestinal
complications, as well as polypharmacy issues, remain a constant concern to both
patients and doctors (3,7-13). In our study, patients were asked to report any
hospitalization as a result of RA medication use and 2 of the 62 patients (3%) who
responded, reported that they had been hospitalized due to RA medications. Benefits
of RA medications more commonly outweigh the risks, however, adjunct therapy may
help reduce symptoms, thereby requiring less medication use. Our study showed highfrequency doses of RA medication was significantly related to lower levels of selfefficacy which in turn were associated with poorer RA outcome measures. Improving
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self-efficacy for those individuals with poor disease prognosis might be challenging,
but our results indicate this relationship may be a very important point for
intervention.
Strengths and Limitations of Study
This was a cross-sectional study, designed to determine strength of association
of lifestyle factors with disease activity. As such, no causal conclusions can be drawn.
Does experiencing more symptoms lead to lower self-efficacy or vise versa?
Controlled intervention trials that specifically target self-efficacy would be necessary
to make this determination.
Because this design studied many factors at the same time, there is an
increased sensitivity of revealing association factors that are not measured by other
study designs (42). Further, despite the small sample size (n=75), highly significant
findings were detected between the predictor variables (diet, exercise, exercise
outcome expectations, and self-efficacy) and RA outcome measures (AIMS2-pain,
RADAR, health satisfaction scores). By the same token, due to the small sample size,
it was not possible to identify individual components of these broader categories of
diet and exercise to determine the specific influence within each area. And though
self-efficacy was by far the strongest predictor for all outcome measures, diet and
exercise remained strong predictors of one or more of the outcome measures even
after controlling for self-efficacy. In this study, diet and exercise were not intercorrelated and appeared to have independent influence on these outcome measures.
The combined scores of diet and exercise in an attempt to measure "lifestyle" did not
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result in any significant relationship to RA. This indicates that diet and exercise are
independent predictors of RA outcomes.
Any study that involves data collected from self-reporting questionnaires risks
the possibility of over- or under-reporting symptoms or lifestyle factors related to RA,
where participants may want to appear better than they are (42). However, if patients
were attempting to respond in this manner, we would have expected a strong
correlation between diet and exercise scores; this was not found (r=.08), indicating that
assurance of confidentiality may have minimized this bias.
Selection bias may have strengthened any significant associations found in this
cross-sectional design if we assume that RA patients who are not currently seeking
medical attention are doing better than those actively seeking treatment. Under this
assumption, our sample likely included the more difficult cases on which to predict
RA outcomes from our predictor variables. Exposing relationships favoring lifestyle,
self-efficacy and improved RA symptoms among this sample, should allow
generalizability to a broader range of RA afflicted individuals.
Further research is needed to explore why non-exercisers still maintain high
exercise outcome expectations and how best to enable them toward regular exercise.
Including an open-ended question, as to why these individuals were not exercising,
would have been helpful in identifying answers to this question.
Conclusion
The results from our study indicate that promoting adjunct therapy of diet and
exercise alone will not be as effective as first identifying and targeting RA patients'
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confidence that they can perform specific behaviors and that performing these
behaviors will lead to fewer symptoms. Personal lifestyle interventions as adjunct
therapy can then be designed to optimize RA disease management.
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Table 4.1 Characteristics of study sample (n=75).

% with
feature

Mean

SD

Range

Age

55.5

14.3

20-90

BMI

26.3

5.5

17.2-41.1

Characteristic
Female

77.2

Caucasian

72.0

Married

63.0

College 1-4 years

44.6

Disease duration > 9 years

64.4

Income > $40,000

48.6

Poor (n=13) or fair (n=39) global assessment

70.3

Very dissatisfied (n=10) or somewhat dissatisfied
34.7

(n=16) with overall health
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Table 4.2 Correlations of predictor variables and outcome measures (n=75).

Diet Score
Exercise Score
Rx Frequency
Self-Efficacy
Diet Outcome Expectations

Exercise

Rx

Self-

Score

Frequency

Efficacy

10

Diet

Exercise

Outcome

Outcome

Expectations Expectations

Patient
Health

AIMS2
Pain

RADAR

Global

Satisfaction Assessment

04

.07

.08

.14

12

.02

.26*

.02

04

.12

09

.17

00

12

02

.02

-.44$

08

13

.44$

.36$

,28*

28*

.26*

.45$

-.72$

78$

.58$

•42$

■47$

19

16

01

.07

-.40$

32$

.29$

.10

.80$

-.54$

22

-.52$

28$

o.
Exercise Outcome Expectations
AIMS2-Pain
RADAR
Health Satisfaction

* Correlation
t Correlation
$ Correlation
Shaded areas

is significant at the < .05 level (2-tailed).
is significant at the < .01 level (2-tailed).
is significant at the < .001 level (2-tailed) - adjusted for Bonferroni.
indicate outcome variable inter-correlations.

.35$

Table 4.3 Regression analysis to determine predictor variables of key outcome measures.
Outcome

Predictor

Stand.

Measures1

Variables

P

t

AIMS2-

ALL (n=60)2
76

-6.784:

.43

6.06

.00001

78

-4.094:

.36

4.31

.001

-.30

-2.32*

.44

-.88

-9.314:

.59

10.69

-.82

-6.444:

.49

5.62

.0001

Self-Efficacy

.59

4.954:

.31

4.39

.0002

Diet Score

.27

2.28*

.36

.41

2.97|

.40

5.51

.0001

-.45

-3.28t

45

.37

2.64t

.54

Pain

Self-Efficacy

Adj.
R2

F

p-value

EXERCISERS (n=43)3
Self-Efficacy
Exercise Score
RADAR

ALL (n=60)4
Self-Efficacy

.000000004

EXERCISERS (n=43)4
Self-Efficacy
Health
Satisfaction

ALL (n=60)4

EXERCISERS (n=43)5
Self-Efficacy
Diet Outcome Expectations
Exercise Outcome Expectations
~

Demographic variables first entered as a block for all analyses: Age, sex, race, marital status, education, annual
income, disease duration, BMI.
2 - Exercise score, Rx frequency, diet outcome expectations, and exercise outcome expectations excluded from
model.
3 - Rx frequency and diet outcome expectations excluded from model.
4 - Diet score, exercise score, Rx frequency, diet outcome expectations, and exercise outcome expectations excluded
from model.
5- Diet score, exercise score and Rx frequency excluded from model.
* Significant at the < .05 level
t Significant at the < .01 level
4: Significant at the < .001 level
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Table 4.4 Secondary model of explanation for predictor variables of self-efficacy.
Stand

Proposed
Mediators1

Predictor Variables

Self-Efficacy

ALL (n=60)2

(AIMS2 pathway)

t

R2

F

-.40

-3.95t

.30

5.42

.00002

.36

3.531

.42

-.42

-3.40t

.34

4.71

.0003

.35

3.01f

-42

-.40

-3.954:

.30

5.42

.00002

.36

3.534:

.42

-.42

-3.40t

.34

4.71

.0003

.35

3.01|

.46

-.42

-4.404:

.32

6.53

.000001

.36

3.844:

.45

-.50

-3.724:

.34

3.41

.004

P

Rx Frequency
Exercise Outcome Expectations

Adj.
p-value

EXERCISERS (n=43)3
Rx Frequency
Exercise Outcome Expectations
Self-Efficacy
(RADAR pathway)

ALL (n=60)4
Rx Frequency
Exercise Outcome Expectations
EXERCISERS (n=43)4
Rx Frequency
Exercise Outcome Expectations

Self-Efficacy

ALL (n=60)4

(Health

Rx Frequency

Satisfaction

Exercise Outcome Expectations

pathway)

EXERCISERS (n=43)5
Rx Frequency

“ Demographic variables first entered as a block for all analyses: Age, sex, race, marital status, education, annual
income, disease duration, BMI.
2 - Exercise score and diet outcome expectations excluded from model.
3 - Diet outcome expectations excluded from model.
4 - Diet score, exercise score and diet outcome expectations excluded from model.
5- Diet score and exercise score excluded form model.
t Significant at the < .01 level
4: Significant at the < .001 level
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Figure 4.1

Regression analysis to determine predictor variables for outcome measures (AIMS2- pain, RADAR,
and health satisfaction) for all subjects.

Regression Analysis for ALL (n

♦ Self-Efficacy (-)

\
\
\
\

♦ Rx Frequency (-)
♦ Reduce
Symptoms by
Exercise (+)

♦ Self-Efficacy (-)

RADAR

Mr = -.54
/

r = -.52
♦ Self-Efficacy (+)
♦ Diet Score (+)

(-) indicates as predictor variable increases, outcome decreases.
f+) indicates as oredictor variable increases, outcome increases.
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Figure 4.2

Regression analysis to determine predictor variables for outcome measures (AIMS2- pain, RADAR,
and health satisfaction) for exercisers only.
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(+) indicates as oredictor variable increases, outcome increases.

\

\
\
RADAR
r = -.57
i
r——Q
i
I r = -.59 i
/
4^

♦ Self-Efficacy (-) hr2 = ,4a

♦ Reduce
Symptoms by
diet (-)
♦ Reduce
Symptoms by
Exercise(+)

\
\

4

jl/

Satisfaction If

CHAPTER FIVE: OTHER FINDINGS
This chapter presents additional findings or details not covered elsewhere in
this document. Specifically, it provides information on detailed demographics, scales
of reliability, comparative data of simultaneous versus "stepwise" regression analysis.
summary data on outcome and predictor variables, and detailed dietary and exercise
results.
Study Population Demographics Predicting RA Outcomes
This study sample was predominantly composed of middle-aged, married
female Caucasians, who were well educated and fairly affluent (refer to Table 5.1).
Table 5.1 Detailed demographic characteristics for study population.
Characteristic
Age (n=75)

Mean and SD
55.5 ± 14.3
(Range 20-80)

Characteristic

Percent

Gender (n=75)
Male
Female

22.7
77.3

Marital status (n=73)
Married
Widowed
Separated
Divorced
Never married
Education (n=74)
< 7 years
7-9 years
10-11 years
High school graduate
1-4 years college
College graduate
Postgraduate

63.0

1.4
13.7
13.7
8.2

Characteristic
BMI (n=73)

Characteristic
Race (n=75)
Caucasian
Black
Hispanic
Indian/Alaskan
Other
Disease duration (n=73)
< 1 year
1-3 years
4-6 years
7-9 years
> 9 years

Mean and SD
26.3 ± 5.5
(Range 17.2-41.1)
Percent

72.0
6.7

18.7
1.3
1.3
6.8

9.6
12.3
6.8
64.4

Income (n=74)
5.5

4.1
5.4

16.2
44.6

9.5
14.9

< 10,000
10,000-19,000
20,000-29,000
30,000-39,000
40,000-49,000
50,000-59,000
60,000-69,000
> 70,000
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16.2
14.9
12.2
8.1
14.9
9.5
5.4

18.9

The demographics indicated higher SES in this study than typically found in the RA
literature (Morgan, et al., 1994; Parker, et al., 1995). Since the demographics had very
little influence RA outcomes (see following section), this should not limit the
generalizability of the results to other RA patient population.
Demographics and AIMS2 - (pain). Based on regression analysis (see Chapter
4), for all subjects and exercisers only, there were no significant individual
demographic variables associated with pain (see Table 5.2 for summary of
demographic impact). Further, when R2 values were adjusted, demographic impact
actually resulted in negative values for pain, thus are reported as "0." The formula for
adjusted R2 values allow the outcome to fall below "0" (Pedhazur, 1982). Adjusted R2
values represent the estimated amount of influence the predictor has on the RA
outcome as applied to the arthritis population with confidence.
Table 5.2 Demographic impact on primary model for RA outcomes.

RA Outcome

Demographic
Adj. R2

Significant
Demographic

AIMS2-pain
All patients (n=60)

.00

None

Exercisers (n=43)

.00

None

RADAR
All patients (n=60)

.00

Annual income

Exercisers (n=43)

.00

None

Health Satisfaction
All patients (n=60)

.05

Gender

Exercisers (n=43)

.17

Gender
Disease duration

Stand, p

t-value

p-value

.31

2.65

.01

31

-2.77

.01

-.30
.28

-2.41
2.44

.02
.02

Demographics and RADAR - (disease activity). For all patients, higher annual
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income was significantly associated with more symptoms of RA (P^.31, p<.01),
though unimportant as indicated by the adjusted R2 value for the combined
demographic variables, a negative value (R2=-.06), and thus reported as "0."
Results were similar for exercisers where demographics had virtually no
influence (adjusted R2=,00) in predicting disease activity, and no significant
demographic predictors surfaced.
Demographics and health satisfaction. For all subjects, demographics explained
5% of the variation in health satisfaction with gender as the predictor (significant
standardized beta coefficient [p=-.26, p<.05]), indicating males were more satisfied
with their overall health.
For the exercise only group, however, demographics explained up to 17% of
the variation of health satisfaction. Being male (p=-.30, p<.05) and increased disease
duration (p=.28, p<.05) were associated with greater health satisfaction.
There were no preconceived expectations in the role that demographics would
play in predicting RA outcomes, nor was this study designed to determine any such
relationship. When demographics were controlled as a simultaneous block,
relationships between identified study variables and RA outcomes were found.
In summary, demographics had little relationship to the RA outcome measures.
However, demographics accounted for more variation in self-efficacy scores, the key
predictor of all RA outcomes (refer to Table 5.3). For all subjects, in this model, of
the eight demographic variables, the significant predictor of self-efficacy was income,
where higher income was associated with significantly less pain and disease activity
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(adjusted R2 for combined demographics =.12; (3=.38, p=.005). Also, those who were
both married (p=.24, p=.04) and had higher income (P=.40, p=.002), were significantly
more satisfied with their health (adjusted R2 for combined demographics =.14).
Table 5.3 Demographic impact on self-efficacy.
Demographic
Adj. R2

Significant
Demographic

Stand.

Self-Efficacy

P

t-value

AIMS2-pain
All patients (n=60)

.12

Annual income

.38

2.91

.005

Exercisers (n=43)

.09

Annual income

.48

3.07

.004

RADAR
All patients (n=60)

.12

Annual income

.38

2.91

.005

Exercisers (n=43)

.09

Annual income

.48

3.07

.004

Health Satisfaction
All patients (n=60)

.14

Marital status
Annual income

.24
.40

2.12
3.24

.04
.002

Annual income

.55

3.21

.003

Exercisers (n=43)

.09

p-value

For exercisers only, combined demographics accounted for 9% of the variation
for all RA outcomes, with annual income as the consistent significant demographic
predictor (see Table 5.3).
Scales of Reliability
In order to determine reliability of various measurement scales used, reliability
analyses were run (see Table 5.4).
Standardized alphas greater than .50 are generally considered reliable. Where
there was a high degree of intercorrelation among subscales within a scale (e.g.,
RADAR), they were combined into a single scale score. In summary, all scales used
were reliable with high alpha values (>.50), providing us with reliable measurements
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on which to base our analyses.
Table 5.4 Reliability results for RA outcome measures and predictors.

Scale

Subscale

n

Number of
scale items

Standardized
alpha

AIMS2-pain

Pain

72

5

.91

RADAR

Pain activity
Function
Joint tenderness

74
74
75
75

3
2
2
3

.92
.64

73

9

.95

71

.83
.94
.84

.92

Combined RADAR
Self-Efficacy (SE)

Function
Pain
Symptoms

Combined SE

72
74

5
6
3

Diet Outcome Expectations

75

2

.96
.86

Regression Analysis - Methodological Comparison.
Regression analysis was used for this study to reveal the degree of association
between identified study variables had three RA outcomes. The decision to use
"stepwise" regression over "enter simultaneous" regression analysis was based on two
reasons. First, this study had a small number of predictor variables. Second, there
was a lack of correlation among our predictor variables (Thompson, 1995). Under
these conditions, stepwise is considered an appropriate statistical approach for
regression analyses. Even so, a comparison of both methods suggest that the results
are so close, that either method will produce near identical results (see Table 5.5 &
Table 5.6). The only additional predictor variable that was significant by using the
"simultaneous" technique that was not revealed as important in the "stepwise" model,
was lower diet outcome expectations for predicting greater health satisfaction. Table
5.6 compares results for exercisers, again revealing similar conclusions, regardless of technique.
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Table 5.5 Linear regression analysis - "stepwise" versus "simultaneous" for all subjects (n=60).

t

Adj.
R2

-.76

-6.78|

.43

6.06 .00001

Simultaneous
Self-efficacy

61

-4.32|

.43

4.25 .0001

Stepwise
Self-efficacy

-.88

-9.311

.59

10.69 .000000004

Simultaneous
Self-efficacy

-.90

-7.24*

.57

6.63 .0000004

Stepwise
Self-efficacy
Diet score

.59
.27

4.95t
2.28*

.31
.36

4.39 .0002

.51
.28

3.31t
2.33*

-36

3.49 .001

-.28

-2.04*

Outcome
measures1

Significant
Predictor Variables

AIMS2-Pain

Stepwise
Self-efficacy

RADAR

Health
Satisfaction

Std. p

Simultaneous
Self-efficacy
Diet score
Diet outcome expectations

F

p-value

1 - Demographic variables entered as a block for all analyses: Age, gender, race, marital status, education, annual
income, disease duration and BMI.
* - Correlation is significant at the < .05 level (2-tailed),
t - Correlation is significant at the < .01 level (2-tailed).
$ - Correlation is significant at the < .001 level (2-tailed).

Table 5.6 Linear regression analysis - "stepwise" versus"simultaneous" for exercisers (n=43).
Outcome
measures1

Significant
Predictor Variables

AIMS2-Pain

RADAR

Health
Satisfaction

Std.

Adj.
R2

P

t

Stepwise
Self-efficacy
Exercise Score

-.58
-.30

-4.09t
-2.32*

.36
.44

4.31

.001

Simultaneous
Self-efficacy

-.40

-2.18*

.44

3.42

.003

Stepwise
Self-efficacy

-.82

-6.441

.49

5.62

.0001

Simultaneous
Self-efficacy
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-4.33|

.46

3.66

.002

F

p-value

Stepwise
Self-efficacy
Diet outcome expectations
Exercise outcome expectations

.41
-.45
.37

2.97|
-3.28t
2.64|

.40
.45
.54

5.51

.0001

Simultaneous
Self-efficacy
Diet outcome expectations
Exercise outcome expectations

.36
-.46
.39

2.11*
-3.19t
2.58f

.51

4.16

.001
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Table 5.6 Linear regression analysis - "stepwise" versus"simultaneous" for exercisers (n=43)
(conO.
1 - Demographic variables entered as a block for all analyses: Age, gender, race, marital status, education, annual
income, disease duration and BMI.
* - Correlation is significant at the < .05 level (2-tailed),
t - Correlation is significant at the < .01 level (2-tailed).
t - Correlation is significant at the < .001 level (2-tailed).

Detailed Dietary Analyses
Results indicate this was a fairly health-conscious group regarding their dietary
intake. Tables 5.7 and 5.8 list the means for individual dietary construct ratings and
raw data. The mid-range value for the individual dietary construct ratings was 2.5.
Most individuals followed a high-carbohydrate, low-fat and low-cholesterol diet with
adequate protein intake. Though the average weekly servings for meat and dairy were
better than the predetermined desirable values for this study (see Table 5.8), the meat
and dairy ratings were considerably worse when rated after the actual servings were
weighted according to fat content (Table 5.7).
Table 5.7 Means and standard deviations for diet ratings and final score.
Dietary variable

n

M and SD

Protein rating
Carbohydrate rating
Fat rating
Saturated fat rating
Cholesterol rating
Fiber rating
Dairy rating
Meat rating
Fish rating

66
66
66
66
66
66
66
66
66

2.5
3.4
2.9
3.5
3.9
1.9
2.2
1.9
1.4

OVERALL DIETARY SCORE

66

23.5 ± 6.9

±
±
±
±
±
±
±
±
±

1.5
1.1
1.1
1.3
1.4
1.6
1.6
1.4
1.0

Range

1
1
1
1
1
1
1
1
1

-

5
5
5
5
5
5
5
5
5

11-39

Though this sample (n=66) was too small for individual dietary construct
analysis, there were important associations found with the diet score and RA outcomes
for all patients and exercisers only. Healthier dietary practices, as indicated by higher
comprehensive diet scores, were associated with significantly less pain.
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Table 5.8 Means and standard deviations for raw dietary constructs.
Dietary construct
Protein (% kcal)
Carbohydrate (% kcal)
Fat (% kcal)
Saturated fat (% kcal)
Daily cholesterol (mg/dl)
Daily fiber (gm)
Meat (actual weekly servings)
Dairy (actual weekly servings)
Fish (actual weekly servings)

n

Desirable

Mean

66
66
66
66
66
66
66
66
66

12.5%

16.0

58%
<30%
<10%
<300mg/dL
>28 gm
<2
<3
>4

53.3

SD
4.3
7.8
6.7

30.1
9.1
231.9
16.9

3.1
116.7
10.8

6.2

4.8

9.7
1.1

9.2
1.4

Range
8.2 - 28.7
35.8 - 68.4

16.8 - 50.6
4.1 - 20.8
29 - 671
2.7 - 65.6
0 - 32
0-42
0-7

Detailed Exercise Analyses
This was a relatively active group. Table 5.9 lists means for all subscales for
exercisers for each category of exercise. The most frequently reported exercise was
walking (n=44; 77%). This was followed by range-of-motion exercises (n=37; 65%).
Among exercisers, 16% (n=9) reported swimming, stationary cycling, and/or other
types of aerobic exercises (such as, belly dancing).
Table 5.9 Means and standard deviations for exercise constructs among exercisers (n=57).
Category
Aerobic

Strength/
Resistance
Stretching/
Flexing

Type of exercise

n

Walking
Running
Swimming
Stationary cycling
Cycling
Aerobics (to music)
Other

44

Calisthenics
Weights
Other
Range-of-motion
Other

% of
exercisers

1
9
9
1

M and SD
in min/session

Range in
min/session

77%
2%

28.2 ± 15.1

7.5 - 53.0

16%
16%

24.4 ± 17.7
10.8 ± 6.6

2%
7%

4

9
1

16%
2%
5%

3
5
37
2

7.5
7.5 - 53.0
7.5 - 22.5

53.0

15.0 ± 8.7
26.0 ± 18.25

7.5 - 22.5
7.5 - 53.0

22.5

9%

22.7 ± 26.3
31.7 ± 13.7

65%
4%

37.8 ±21.6

7.5 - 53.0
22.5 - 53.0

±
22.5 -53.0

Table 5.10 shows most exercisers were performing some form of exercise daily (n=42;
74%). Additional frequency details are listed in Table 5.11 for each category for all patients
(n=75), which shows aerobic exercise as the most frequent exercise category performed with
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regularity, followed by flexibility exercises. Eighty-five percent (n=6A) of this study group
performed no strength/resistance exercises, indicating a significant need to educate and train
RA patients of the types of resistance exercises that are both efficacious and safe.
Table 5.10 Exercise frequency among exercisers (n=57).
Frequency

n

Percent

1-2 times weekly
3-4 times weekly
5-6 times weekly
Daily

5
4
6
42

9%
7%

Table 5.11

Frequency for exercise frequency data for all subjects (n=75).

Exercise category
Total Stretching/Flexing

Total Strength/Resistance

Total Aerobic

11%
74%

Times per
week

Frequency

Percent

None
1-2 times
3-4 times
5-6 times
Daily

30

40.0
20.0

9
2
19

2.7
25.3

None
1-2 times
3-4 times
5-6 times
Daily

64
2
3
0
6

85.3
2.7
4.0
0.0
8.0

None
1-2 times
3-4 times
5-6 times
Daily

19

25.3
14.7

15

11
13
5
27

89

12.0

17.3
6.7
36.0

Cumulative
percent
40.0
60.0
72.0
74.7

100.0
85.3
88.0
92.0
92.0

100.0
25.3
40.0
57.3
64.0

100.0

CHAPTER SIX: DISCUSSION
This cross-sectional study revealed significant associations between lifestyle
and symptoms of rheumatoid arthritis as well as self-efficacy and symptoms of RA.
Self-efficacy was the strongest and most consistent factor associated with disease
activity, pain and health satisfaction.
In this study, lifestyle was only important in predicting RA symptoms after
including self-efficacy in the model. In addition, no correlation existed between diet
and diet outcome expectations indicating that even if patients were following healthy
diets, they did not believe that in doing so their symptoms of RA would improve.
Finally, even non-exercisers had high exercise outcome expectations indicating they
believed exercise would be beneficial in reducing symptoms of RA. Discovery of
reasons for inactivity could present intervention opportunities to move sedentary
patients into some form of regular exercise.
Association of Self-Efficacy and Outcome Expectations with RA Outcomes
This study showed that among this sample of RA patients, those who had a
higher level of self-efficacy regarding their ability to perform daily functions and
control pain and symptoms of RA, reported fewer RA symptoms and were generally
more satisfied with their health. These results are supported by other studies, both
cross-sectional and controlled-intervention trials, that show fewer symptoms related to
rheumatoid arthritis, such as pain and depression, when patients had high self-efficacy
(Brus, van de Laar, Taal, Rasker, & Wiegman, 1997; Bueshcer, et al., 1991; Parker, et
al., 1995; Smith & Wallston, 1992). The current study demonstrated highly significant
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and stronger adjusted, R-squared multiple regression values than are generally reported
adding strength to present and past research regarding self-efficacy and RA outcomes.
This is important because past research has shown that when patients perceive greater
control over their disease, reported pain is lower and patients report more activity
despite additional physical impairment (Lorig, et al., 1993). And since there is
currently no cure for RA, ways of reducing symptoms need to be explored and
validated.
Lorig and colleagues (1989) conducted a controlled intervention trial where the
intervention group followed the Arthritis Self-Management Course (Lorig, 1984). At
the conclusion of the study, within and between group differences favored the
intervention group who reported higher levels of self-efficacy and fewer symptoms of
RA compared to the control group. Positive results were also found in Parker and
colleagues' study (1995) where patients (n=47) who underwent a 10-week stress
management course with a 15-month follow-up maintenance showed significantly
improved self-efficacy, reduced depression, less helplessness and increased coping
strategies compared to the control group (n=45) and the attention-control group (n=49)
which received computerized health education only. Our study showed that even
without intervention, patients with high self-efficacy reported fewer symptoms of RA.
Evidence from the literature supports the conclusions found in our study
suggesting self-efficacy, the belief that one can perform a specific behavior, is critical
in the outcome of RA patients. The present study found those with high self-efficacy
not only experienced fewer symptoms of RA, but were generally more satisfied with
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their overall health. Additionally, higher self-efficacy was associated with using fewer
doses of RA medication. Self-efficacy levels related to specific behaviors, such as diet
and exercise, should be evaluated prior to implementing lifestyle changes in RA
patients to determine which self-efficacy skills need to be enhanced to facilitate
positive RA outcomes.
Though this study was not designed to test Bandura’s Social Cognitive Theory,
this did serve as the theoretical foundation for selecting variables and measures to
include. As such, an instrument to measure outcome expectations was necessary.
However, no such tool was found, nor were any direct measurements of outcome
expectations reported in the literature. Lorig and colleagues (1989) make reference to
the relationship of self-efficacy with outcome expectations on performing a behavior,
but only developed a self-efficacy measurement scale for patients with RA. This study
specifically set out to measure outcome expectations and determine the relationship
with self-efficacy and RA outcome measures. Three questions were developed that
measured RA patients' outcome expectations regarding lifestyle and symptoms of RA
(see Appendix E).
Diet and outcome expectations. Though a healthy diet was found to be
significantly associated with less pain among all subjects (n=60), there was no
association between diet and diet outcome expectations (r=-.10). The sample size may
not have been large enough to detect a relationship. Also, the outcome expectation
questions may have been too general to detect any specific relationship pertaining to
dietary patterns and dietary expectations on RA outcomes. Two questions relating to
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diet addressed the consumption and the omission of certain foods improving RA
symptoms without making reference to specific types of food. Providing a broad
range of questions may have detected a true relationship between diet and diet
outcome expectations. Or diet and diet outcome expectations may be simply
independent predictors of RA symptoms.
Among exercisers (n=43), low diet outcome expectations were found to be
associated with greater health satisfaction. There is no logical explanation for this
result, unless individuals view "diet” as a negative or restrictive activity and are more
satisfied with the belief that diet will not improve RA symptoms, therefore they can
consume any foods. Also, health satisfaction was measured with a single question and
open to the interpretation of each patient. This question may have been too general to
accurately assess patients' level of health satisfaction, obscuring any logical
relationship with diet outcome expectations.
It was anticipated that a low-fat, low-animal product diet would play a positive
role in RA outcomes. However, the sample size was too small to detect associations
between individual dietary constructs and RA outcomes. Initial analysis revealed a
significant (r=.25, p<.05) relationship between frequency of dairy consumption and
pain, but no other significant associations between individual dietary constructs and
RA outcomes were found. Due to the lack of association of dietary constructs to RA
outcome measures and the small patient sample, the development of a single diet score
was necessary. Daily food frequency of macronutrients, fiber and cholesterol were
compared then rated to those guidelines set for the United States (U.S. Senate Select
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Committee on Nutrition and Human Needs, 1990). Additionally, three constructs that
measured and rated the frequency of dairy, fish and meat consumed were created.
Correlation analysis showed that higher dairy ratings (less dairy products consumed)
were associated with greater health satisfaction (r=.35, p=.004). All individual
construct ratings were combined to represent an overall dietary pattern. A healthy diet
was predictive of greater health satisfaction for all subjects.
The data from this cross-sectional study suggest that a sensible comprehensive
diet may be more important than any single dietary element for predicting RA
outcomes. Recommendations toward healthier dietary patterns for patients of RA
would be a safe lifestyle approach. Because these recommendations have been
suggested over many years, safety concerns would have surfaced. Further, there is a
clear indication that dietary compliance to extreme changes or regimens is frequently
problematic in many RA study designs (Beri, et al., 1988; Kavanagh, et al., 1995;
Kjeldsen-Kragh, et al., 1991). RA patients needing to change current dietary patterns
may be able to adhere to less extreme recommendations. Adherence can lead to
lifestyle changes rather than temporary "dieting" to achieve positive RA outcomes.
And though dietary outcome expectations did not lead to less pain or fewer symptoms
of RA in this study, past research has shown improved compliance for individuals who
believe in more non-traditional therapy for treatment of RA (Kjeldsen-Kragh, Haugen,
et al., 1994). Additional research is needed in order to validate and produce reliable
conclusions, but clearly diet is emerging as an important adjunct therapy for RA
patients.
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Exercise and outcome expectations. Our study found that 76% of the RA
patients engaged in some form of exercise. Among exercisers, those who exercised
more frequently experienced significantly less pain (AIMS2).
Higher self-efficacy among exercisers was related to the same patterns found
among all patients: less pain (AIMS2), less disease activity (RADAR) and greater
health satisfaction. In addition, higher exercise outcome expectations in controlling
disease were related to higher self-efficacy scores, even among those who did not
exercise at all, and experienced benefits (fewer RA symptoms). This indicates that
sedentary patients believed exercise would be beneficial but for some reason did not
exercise. These individuals may not have exercised because they had incurred
permanent disability limiting their perceived ability to exercise. There was no
significant difference between exercisers and non-exercisers for mobility (p=.26) in
this study group. However, efforts should be made to identify patients with poor
mobility who have high outcome expectations to offer alternative exercises that could
improve RA outcomes. Careful assessment of functional capacity would allow health
professionals to recommend specific forms of physical activity to match individual
ability. The literature supports various forms of exercise (swimming, resistance
training, cycling) as beneficial to RA outcomes. This study represented exercise as a
single combined score and as such can not attribute a specific exercise modality to the
reduction of pain or improved health satisfaction. However, the majority of exercisers
reported walking as their primary mode of exercise (n=44; 77%). Additionally, results
indicate regardless of the exercise mode, cumulative time and frequency of exercising
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showed more improved RA outcomes.
Past research supports the idea that various forms of exercise improve RA
disease status or attributes no further joint destruction than would have occurred in the
normal RA disease pathogenesis (Lynberg, et al., 1994). Strength training during non
acute stages prevents muscle wasting (Komatireddy, et al., 1997; Rail, et al., 1997;
Stenstrdm, 1994). Improvements gained from exercise include increased mobility and
decreased pain. Aquatic training during non-acute stages of disease can also increase
the level of mobility and patients functioned more effectively in their daily activities
due to improved muscle strength (Minor, et al., 1989; Stenstrdm, Lindell, Swanberg,
Swanberg, Harms-Ringdahl, & Nordemar, 1991). Similar increases in daily function
and patient global assessments (a patient's overall assessment of their current
condition) were found in patients who applied stationary cycling at low-intensity levels
(Harkcom, et al., 1985). There is also evidence that physical rehabilitation upon early
disease diagnosis decreases the risk of future bone deterioration (Semble, 1995).
The RA patient differs from the general population during acute stages when
exercise might be limited to range-of-motion activities and low-impact aerobic exercise
of short duration. However, during non-acute phases, RA patients are limited only by
their ability to perform activities due to their incurred level of RA physical disability.
Those individuals without major joint damage are capable of physical activities
generally experienced by the normal population.
This study clearly identified, that among exercisers, there was a significant
association between increased duration of exercise of any type to less pain. This
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provides evidence for individual flexibility in designing exercise programs with the
patient and stresses the importance of exercise and disease.
Medications and self-efficacy. This study showed individuals who consumed
RA medication more frequently had significantly lower self-efficacy scores. These
individuals were likely to have been more debilitated, requiring higher doses of
medications to control exacerbated symptoms as indicated by less satisfactory levels of
mobility. When examining patients at the high- and low-end of dose consumption,
mean AIMS2-pain scores were significantly worse for individuals consuming RA
medication >5 times daily (n=T0) compared to those consuming RA medications < one
time daily (n=24; [M and SD 5.0±1.4 versus 2.2±2.2]; t=-3.7, p^.001). Similar
patterns were found for mean RADAR scores (M and SD 7.4±2.8 versus 4.4±3.3;
t=-2.5, p=.02) and less health satisfaction (M and SD 2.5±1.6 versus 3.6±1.4; £=2.0,
p=.05). This indicates medication use is related to poor RA outcomes. Because selfefficacy is low in patients with high RA medications use, enhancing self-efficacy for
performing daily functions can improve RA outcomes.
Table 6.1

Independent t-tests for low- and high-medication use and RA outcomes.

RA Outcome
AIMS2-pain

RADAR

Health
Satisfaction
Self-efficacy

SD

Daily Rx Use

N

Mean

< 1 time daily

24

2.2

2.2

> 5 times daily

10

5.0

1.4

< 1 time daily

24

4.4

3.3

> 5 times daily

10

7.4

2.8

< 1 time daily

24

3.6

1.4

> 5 times daily

10

2.5

1.6

< 1 time daily

24

73.5 ±

17.6

> 5 times daily

10

47.9 ±

16.0
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t-value

p-value

-3.7

.001

-2.5

.02

2.1

.05

4.0

.0004

There were obvious limits of sensitivity to prescribed doses related to specific
drug classifications, since the medication rating in this study entailed reporting the
frequency of combined RA medications per week. One of the current most effective
RA medications, methotrexate, requires the least amount of doses in a week's time
(Simms, et al., 1996). Individuals who used this medication should therefore have
reported the lowest frequency of medication use. However, when selecting cases for
regression analysis that only included patients on methotrexate (n=62), higher
frequency of medication use was still associated with lower self-efficacy scores
(combined adjusted R2=.39 with exercise outcome expectations; p=.0001). Though not
statistically significant, the mean number of doses of medications per week were
actually higher for those taking methotrexate (M and SD 19.3±17.6) compared to those
who were not on methotrexate (n=13; M and SD 16.5±15.6). Results showed
individuals on methotrexate were taking multiple drugs to treat their RA. This also
suggests taking any medication for RA may be related to low self-efficacy. This
highlights the complexity of treating RA: there is currently no single medication able
to control for all symptoms of RA for most patients. Nearly all of the patients (^=67;
89%) in the present study reported use of multiple classes of medications for RA
therapy. Clearly medication use was related to low self-efficacy which in turn was
related to worse RA outcomes. Improving self-efficacy for these individuals will be
challenging, but results indicate that this relationship is an important point for
intervention.
Strengths and Limitations of Study
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This was a cross-sectional study, designed to determine strength of association
of lifestyle factors over RA disease activity. As such, no causal conclusions about the
effect of diet and exercise on RA outcomes can be drawn. Because this study
examined many factors at the same time, there is an increased sensitivity of revealing
associations that are obscured through other study designs (Cook & Campbell, 1979).
Despite the small sample size (n=75), highly significant results were found among the
predictor variables and outcome measures, showing the importance of higher levels of
self-efficacy and a healthy lifestyle, as indicated by a healthy diet and exercise, and
their relationship to improved RA indicators. By the same token, due to the small
sample size, it was not possible to identify individual components of these broader
categories of diet and exercise to determine any significant influence within each
subscale. For instance, the specific relationship of meat consumption and dairy
consumption to RA indicators was difficult to determine although overall, a diet with
higher scores indicate a healthier eating pattern and were associated with greater health
satisfaction. And though self-efficacy was by far the strongest predictor all RA
indicators, diet and exercise remained strong predictors of one or more of the outcome
measures, even after controlling for self-efficacy. In this study, diet and exercise were
not inter-correlated and appeared to have independent influence on these outcome
measures. The combined scores of diet and exercise in an attempt to measure
"lifestyle" did not result in any significant relationship to RA. This indicates that diet
and exercise are independent predictors of RA outcomes.
Any study that involves data collected from self-reporting questionnaires risks
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the possibility of over- or under-reporting symptoms or lifestyle factors related to RA,
where participants may want to appear better than they are (Cook & Campbell, 1979;
Willett, et al., 1985; Willett & Stampfer, 1986). However, given that there was no
correlation between diet and exercise, the subjects in this study appeared not to be
consistently reporting a combined healthy lifestyle or RA outcomes. Also, most
reported medication use, which may have been interpreted as "unhealthy." Assuring
confidentiality of responses was intended to minimize this bias of socially desirable
responding.
Selection bias of using RA patients actively seeking treatment may reduce the
generalizability of the results. However, assuming that RA patients in active therapy
would offer a broad range of cases of which to assess (good and poor responders to
treatment), it is postulated that if relationships favoring lifestyle or self-efficacy are
exposed among this sample the results would then be applicable even to those not
currently seeking treatment.
In summary, this cross-sectional study of lifestyle and RA shows that, despite
limitations, a significant relationship exists between healthier diet and regular exercise
and fewer symptoms of RA or greater health satisfaction when self-efficacy is high.
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CHAPTER SEVEN: RECOMMENDATIONS AND CONCLUSIONS
This study found there is clearly a relationship among self-efficacy, lifestyle
and symptoms of rheumatoid arthritis. Based on this current research the following
recommendations are proposed.
Future Research Recommendations
1.

Determine temporal issues for self-efficacy. Though this cross-sectional study

associates higher self-efficacy with fewer reported symptoms of RA, the question
arises: Does higher self-efficacy lead to fewer symptoms of RA or do patients who
experience fewer symptoms of RA have higher self-efficacy as a consequence of their
less severe condition? Controlled longitudinal intervention trials can address more
fully the causality issue.
2.

Determine reasons for sedentary behavior. Further research needs to explore

why non-exercisers held high exercise outcome expectations despite the fact that they
were not currently exercising. Including an open-ended question as to why these
individuals were not exercising would have been helpful in addressing this issue.
Social Cognitive Theory states that a person needs to believe that they can perform a
behavior, but that they also need to believe that the behavior will lead to a desired
outcome (Bandura, 1997). Incurred RA debilitation may limit activity options
(sedentary behavior), even though a RA patient believes that exercise will result in
fewer RA symptoms.
3.

Include a comprehensive dietary analysis. The diet assessment tool used in this

study was to identify those who followed healthy eating patterns as determined by
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degree of adherence to recommended dietary guidelines for the United States.
However, due to the small sample size (diet responders: n=66), it was difficult to
determine which, if any, of individual constructs of the diet were related to RA
outcomes. Though the Nutrition Profile© pamphlet provides caloric distribution of
macronutrients, this forty-five question dietary tool may lack accuracy that provides
evidence of existing relationships between specific dietary components and RA
symptoms. Or, it may be that overall diet is more important than any single
component. A larger sample size is recommended in future research to permit a more
comprehensive diet analysis to test this theory utilizing a more sensitive dietary
assessment tool.
4.

Determine basis for dietary outcome expectations. It was unclear why those

who followed a healthier diet did not think that the diet would have any beneficial
results on their disease outcome (e.g., low outcome expectations). Among exercisers,
low diet outcome expectations were associated with greater health satisfaction. A
more detailed diet outcome expectation tool should be developed to allow for a
broader range of questions and answers.
5.

Develop self-efficacy questions designed to measure lifestyle. The current tool

for self-efficacy predominantly measures patients' coping and functional behavior
related to RA (Lorig, et al., 1989). This tells us nothing about their belief in their
abilities to perform specific exercises or compliance to a recommended diet. Bandura
(1997) states that self-efficacy is specific to behaviors and situations, and as such, a
tool that measures lifestyle should be developed. New questions relating to RA
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patients' self-efficacy for exercise performance or dietary changes need to be
developed in order to assess more fully any relationship between self-efficacy, lifestyle
and RA symptoms.
6.

Differentiate medication use. While gathering data in the waiting room

facilities, several patients commented on the medication portion of the survey. They
stated that in order to counter the side-effects of RA medications, such as gastro
intestinal distress or pain, drugs such as Tagamet were used. The reported frequency
of RA medication use was already considerably high (M, SD=T8.8 doses/week ± 17.2),
yet did not include medications to control the side effects of RA medications or other
co-morbidity medications (e.g., antihypertensives). Though no direct association was
found between lifestyle and medication use, higher medication use was associated with
significantly lower self-efficacy, more RA symptoms and lower health satisfaction.
Including additional medication categories for RA patients to report would likely
strengthen these associations. Results indicate that patients consuming higher doses of
medications were experiencing the most symptoms. Alternative or adjunct therapy
should be explored for RA patients no longer responding favorably to RA medications.
The development of a comprehensive, yet simple form that patients can easily
complete for drug assessment is needed. The tool developed for this study was
comprehensive regarding RA medication use, but was not user-friendly as indicated by
incomplete responses (refer to appendix E). And though there was a statistically
significant relationship between the frequency of medication use per week and selfefficacy and other RA outcomes, it would have been more informative to identify
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whether a certain class of drug was more sensitive to dose response and symptoms of
RA.
Recommendations for Preventive Care Specialist
In summary, the key recommendations from this research are that Preventive
Care Specialists can assist RA patients in several ways in order to improve their
current RA condition through lifestyle intervention, which first explores the patients
level of self-efficacy. Typically, Preventive Care Specialists counsel patients on
primary prevention, yet chronic disease, like RA, will be a major portion of their
patient population, particularly as the aging of America continues to tip the scale
towards a significant increase in an older population. Though medication will always
play a prominent role in the treatment of RA disease, secondary prevention can
minimize negative disease outcomes (Berg & Cassells, 1992).
This study was designed to determine if there was an association between
lifestyle (including diet and exercise) and RA symptoms. Relationships between selfefficacy and RA symptoms were also explored to determine other points of
intervention to improve RA outcomes. The following research questions were asked:
1)

To what degree do lifestyles that incorporated low-fat, low-animal
product diet and regular exercise improve disease stability in patients
with rheumatoid arthritis?

2)

Do RA patients who follow a healthier lifestyle, one that included a
low-fat, low-animal product diet and regular exercise, have higher selfefficacy and outcome expectations than those who did not lead this
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lifestyle?
3)

Do RA patients with high self-efficacy experience fewer symptoms of
RA?

The answers to these questions and the implications for Preventive Care
Specialists are addressed below.
Question one. Regression analysis indicated that RA patients leading healthier
lifestyles, as defined by a healthy diet and regular exercise, reported better RA
outcomes (see Chapter 4, Tables 4.3 and 4.4, and Figures 4.1 and 4.2). Diet was
associated with greater health satisfaction and among exercisers, increased amount of
exercise was associated with less pain.
Initially, the intent was to study the effects of a diet low in fat and animal
products. While the small sample size did not permit the analysis of individual dietary
variables measured to RA outcomes, a comprehensive dietary score did show the
importance of following a healthy overall diet. Prior to rating individual dietary
constructs, when dietary components and RA outcomes were analyzed for correlations,
increased dairy consumption was the only individual component significantly related to
RA outcome measures, specifically more pain (r=.25, p=.04). However, the combined
scores of the individual diet constructs were significantly related to greater health
satisfaction as diet scores increased (indicating a healthier diet).
From these results, it is difficult to make strong recommendations for specific
dietary changes. These results do suggest, however, that a single component of the
diet may not be as important as the general pattern of the diet itself. The individual
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diet constructs were compared and evaluated against dietary guidelines set forth for the
United States (U.S. Senate Select Committee on Nutrition and Human Needs, 1990).
Additional constructs (as determined important for RA patients based on previous
research) were frequency of meat, dairy and fish consumption. Individuals with higher
overall diet scores were found to have greater health satisfaction, suggesting a dietary
pattern is important in RA outcomes. Therefore, Preventive Care Specialists can
safely recommend a sensible comprehensive diet similar to that of the U.S. dietary
guidelines for RA patients to improve RA outcomes.
Question two. Based on regression analysis, a healthy diet was associated with
greater health satisfaction (Table 4.3 and Figure 4.1). Among exercisers, increased
exercise was associated with less pain (Table 4.4 and Figure 4.2).
There were significant associations between self-efficacy and diet outcome
expectations (r^.26, p=.02) and exercise outcome expectations (r=.45, p=.00002). It is
important to note, according to Bandura (1997), that both self-efficacy and outcome
expectations need to be high in order to promote behavioral changes. The results of
this study partially support Bandura's Social Cognitive Theory (1997); as exercise
outcome expectations were high and self-efficacy was high, less pain was reported
even among non-exercisers. However, diet outcome expectations were not predictive
of diet behavior, even if self-efficacy was high, though a healthy diet was associated
with greater health satisfaction for all subjects and among exercisers when selfefficacy was high. This suggests that diet alone is predictive of RA outcomes and that
little relationship exists between self-efficacy and outcome expectations for diet and
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RA symptoms. It should be noted that the self-efficacy scale predominantly measured
function and coping with RA, and was not specific for dietary or exercise compliance.
If there was a self-efficacy tool designed to specifically measure lifestyle (diet and
exercise), perhaps a relationship would be detected with the outcome expectations
assessment designed for this study. Also, the lack of association between diet
outcome expectations and RA symptoms may indicate the questions were too broad
and did not accurately represent the patients expectations.
Development of a more accurate tool to measure self-efficacy and outcome
expectations for lifestyle is needed. Even so, based on results from this study,
Preventive Care Specialists can find the two key constructs of self-efficacy and
outcome expectations from the Social Cognitive Theory useful. Assessing a patient's
self-efficacy and outcome expectations, as related to lifestyle, prior to implementing
changes, may help promote positive RA outcomes. Preventive Care Specialists can
enhance self-efficacy, or confidence in controlling their disease, by setting small
achievable goals individually with the RA patient. Gradual shaping with small steps
of repetitive behaviors is the best method of improving self-efficacy (Bandura, 1997).
Patients can be encouraged to keep a journal or diary logging successes. Modeling of
a desired behavior is also an effective technique to increase self-efficacy, by which
patients can observe other RA patients effectively coping with outcomes of the disease
process (1997). Modeling would likely work best in group counseling or support
groups, where patients are able to share their experiences and the methods they find
most effective in improving self-efficacy for specific behaviors.
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The Social Cognitive Theory is reciprocal in design where the patient performs
a behavior based on beliefs and outcome experiences. The first question a patient may
ask is, "Can I do it?” followed by, "If I do it, will it help?” These two questions
represent self-efficacy and outcome expectations. According to Bandura (1997), it is
not enough to think you can perform a behavior; there is also a need to believe the
performance will lead to desired results. This model allows Preventive Care
Specialists to assist patients as they move through lifestyle changes and overcome
barriers. Though diet outcome expectations in this study did not indicate a
relationship with self-efficacy or RA outcomes, it is still important to educate
individuals on the benefits of a healthy diet. And since a healthy diet was a predictor
for greater health satisfaction when self-efficacy was high, enhancing self-efficacy may
be a sufficient initial intervention. Increasing self-efficacy for adherence to a healthy
diet would then allow patients to develop outcome expectations built on the experience
of dietary compliance, where their question becomes, "Did it help?”
Question three. For all patients (n=60) and among exercisers (n=43), selfefficacy was the strongest predictor for all outcome expectations (pain, disease activity
and health satisfaction). Table 4.3 Figure 4.1 delineate the clear relationship along
with the strength of this association. As self-efficacy increased, patients reported less
pain and disease activity, and were more satisfied with their overall health. Further,
when self-efficacy was assessed as the mediator for RA outcomes, additional
relationships were exposed, such as low-frequency doses of medication and high
levels of self-efficacy linked with improved RA outcomes (Table 4.4 and Figure 4.2).
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The statistical significance reported in this study regarding the relationship between
self-efficacy and improved RA outcomes, supports PCSs implementing efficacy
enhancement techniques into the treatment of RA patients to help reduce RA
symptoms.
Conclusions
Preventive Care interventions for RA patients can start by the practitioner
assessing self-efficacy and outcome expectations as related to dietary compliance and
exercise performance. Due to the importance of self-efficacy and its clear relationship
to RA outcomes in this study, it would be inadvisable to make dietary and exercise
recommendations without first addressing this factor. The ultimate goal in RA therapy
for a Preventive Care Specialist is to improve quality of life for these patients, because
while there is currently no cure for RA, there are ways to reduce RA symptoms.
There are many issues surrounding any chronic disease, such as coping with
depression, pain, physical impairment, and an increased need for social support, as the
disease creates disabilities (Sammuelsson, et al., 1993). Identifying perceived barriers
for each patient will help develop realistic achievable and maintainable goals that can
in turn increase self-efficacy for lifestyle behaviors.
Alternative exercises are available to those with disabilities so they will benefit
from exercise without exacerbating their disease (Danneskiold-Samsoe, et al., 1987).
This current study found increased duration of any exercise performed with regularity
was associated with improved disease status. According to the recent Surgeon
General's report on sedentary lifestyles, brief bouts of exercise that cumulatively total
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30 minutes daily, still offers significant health benefits (Corbin & Pangrazi, 1994).
And though additional benefits can be gained for those who increase their exercise
duration, health benefits are gained if the amount is cumulative, rather than a single
long-duration event. This allows flexibility for RA patients with physical impairments,
unable to withstand long episodes of exercise.
After evaluating self-efficacy and dietary outcome expectations, comprehensive
dietary counseling can include dietary goals for the U.S. (U.S. Senate Select
Committee on Nutrition and Human Needs, 1990) which promote a low-fat diet, high
in complex carbohydrates and fiber. Though meat, fish and dairy consumption were
also part of the overall diet score in the current study, individual food constructs were
not specifically measured for relationships to RA outcomes due to the small sample
size.
Typically, extreme changes in the diet leads to poor adherence (Beri, et al.,
1988; Kavanagh, et al., 1995; Kjeldsen-Kragh, et al., 1991) for long-term changes.
But creating smaller steps toward long-term goals could lead to permanent changes.
Initially, Preventive Care Specialists can analyze the RA patient's diet to recommend
gradual changes, such as changing from high-fat items to low-fat (e.g., using ground
turkey instead of ground beef). This could be followed by reducing serving size, then
frequency of meat products while increasing favorite complex carbohydrates. High
patient participation in meal planning will offer the patient ownership with each
change. Through small dietary steps, a comprehensive healthy diet can be achieved
and lead to permanent lifestyle changes. Individualized treatment and continued
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reassessment, working in conjunction with the rheumatologist should produce the most
favorable outcomes.
In summary, the results from this study indicate that promoting adjunct therapy
of diet and exercise alone will not be as effective as first identifying and targeting RA
patients' confidence that they can perform specific behaviors and that performing these
behaviors will lead to improved RA outcomes. Applying Bandura's Social Cognitive
Theory, personal lifestyle interventions can then be designed to enhance their
confidence in behavior performance, which should lead to fewer symptoms and create
a positive-reinforcement pattern.

Ill
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Appendix A
Subject Flowchart
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Appendix B

INSTITUTIONAL REVIEW BOARD

|OSR# 47155| y>

Initial Approval Notice • Expedited Review
OFFICE OF SPONSORED RESEARCH • 11188 Anderson Street • Lome Linde, CA 92350
(909) 824-4531 (voice) • (909) 478-4131 (tax)

To:

Department
Protocol:
Date:

Helon P. Hopp, PhD
Health Promotion & Education
A cross-sectional study examining lifestyle and rheumatoid arthritis
06/25/1997

The protocol and consent form for this study were reviewed and approved administratively on behalf of
the IRB. This decision includes the following determinations:
1. Risk to research subjects: Minimal
2. Approval period begins 06/25/1997 and ends 06/24/1998.
3. Conditions of approval are: <None Specified>
Consent Form
If a written consent form is required, approval will be indicated by the affixed IRB approval stamp. This
now becomes your official consent form for the dates specified and should be used as a master for
making the necessary copies.

Adverse Events / Protocol Changes
The IRB should be notified in writing of any modifications to the approved research protocol. All adverse
effects, anticipated or not, should be reported to the IRB: serious events should be reported within seven
days; all others within 15 days.

Protocol Review
Your protocol is tentatively scheduled for review and renewal at the meeting of the IRB in June 1998.
To assure uninterrupted approval of this project, you will be sent a status report form to complete and
return prior to this date. In addition to reporting the number of subjects enrolled, you may close the study
or request renewal at this time.
Records
All records relating to this project, including signed consent forms, must be kept on file for three years
following completion of the study.
Please note the Pi's name and the OSR number assigned your IRB application (as indicated
above) on any future communications with the IRB about this project. Direct all communications
to the IRB do the Office of Sponsored Research.
Thank you for your cooperation in LLU's shared responsibility for the ethical use of human subjects in
research.
Signature of IRB Chair/Vice Chain,

Date:

<r

Tht InsMution* Rmiaw Board holds MPA No M-1295 win tha U S. Offica lor Protection horn Research Risks lor these affiliated insUUions: Lome Linda University,
Lome Linda Umversily Medical Center, Lome Linda University Children’s Hospital, Loma Linda University Faculty Medical Group.
Loma Linda University Community Metical Center. Loma Linda University Behavioral Medicine Center
Administrative Contact:
Ian M. Fraser, PhD. Vice Presideni
Academic end Research Alton
(909) 824-4542

IRB Chain
G. William Saukel, M.D.
Department of Pathology
(909) 824-4794
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Executive Secretary:
Linda G. Halstead, M.A, Assoc. Director
Office of Sponsored Research
(909) 824-4531, emaillhalsteadQccmaiLttu.edu

Appendix C
'A Cross-Sectional Study Examining Lifestyle and Rheumatoid Arthritis"
Purpose. I have been invited to participate in a research study because I have
rheumatoid arthritis. The purpose of my participation is to gain information about my
rheumatoid arthritis and my current lifestyle. My participation will last approximately
25 to 60 minutes. My participation will involve completing a questionnaire centering
around my rheumatoid arthritis. I understand that it may be a necessary to examine
my medical records.
Risks, Rights, and Benefits. The committee at Loma Linda University that
reviews human studies (Institutional Review Board) has determined that participating
in this study exposes me to no physical risk. I understand that while I will not benefit
personally, the benefits to humanity from my participation include the development of
knowledge that might help direct future therapy in rheumatoid arthritis. I understand
that my participation in this study is voluntary. My decision whether or not to
participate or terminate at any time will not affect my present or future medical care.
There is no additional cost to me for participating in this study.
Confidentiality. The information I provide on the questionnaire will remain
confidential. I understand that any published document resulting from this study will
not disclose my identity.
Impartial Third Party Contact I understand that if I wish to contact an
impartial third party not associated with this study regarding any complaint I may have
about the study, I may contact Jean Fankhanel, Patient Representative, Loma Linda
University Medical Center, Loma Linda, CA 92354, phone (909) 824-4647 for
information and assistance.
Informed Consent Statement I have read the contents of the cover letter and
the consent form and have received a copy. I understand that if I have further
questions regarding the completion of this questionnaire, or concerns, I may contact
Leslie Nazaroff during routine office hours at (909) 824-4643 or during non-office
hours at (909) 822-6567 and ask for Leslie Nazaroff. I hereby give voluntary consent
to participate in this study. Signing this consent document does not waive my rights
nor does it release the investigators, institution or sponsors from their responsibilities.

Signature of Subject

Date
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Signature of Witness

Appendix D
'A Cross-Sectional Study Examining Lifestyle and Rheumatoid Arthritis"
Thank you for your consideration to participate in a study about rheumatoid
arthritis. My name is Leslie Nazaroff. I am a doctoral candidate at Loma Linda
University, School of Public Health. Your participation in this study will help
determine the association of lifestyle and the disease activity of rheumatoid arthritis.
Information gained from the study may help in future therapy for persons with
rheumatoid arthritis.
If you decide to enter the study, your participation will involve completing a
single questionnaire regarding your rheumatoid arthritis experience and various aspects
of your current lifestyle. You are encouraged to fill out the questionnaire in the
waiting room of these facilities. When you are finished, you will please place the
completed questionnaire back in the envelope provided, seal the envelope and return
the envelope to the front desk. If you are unable to complete the questionnaire at this
time, you may take it home and return it by mail with guaranteed postage using the
envelope provided at the front desk. It is very important that all questions are
answered, so if you feel rushed, please finish the questionnaire at home at your leisure.
It will take approximately 25 to 60 minutes to complete.
Should you agree to participate, prior to completing the questionnaire, please
read and sign the consent form. There are two copies of this form. The set stapled to
the questionnaire need to be signed, dated, witnessed and returned with your
completed questionnaire. The second set are your copies to be signed, dated and
witnessed and retained by you for your information.
Whether or not you decide to participate in this study, you should have
received an envelope marked "Thank you" which contains a small token of
appreciation. If you have not received this separate envelope, you may ask for it at
the front desk. At this time if you have decided not to participate, please keep the
complementary gift, but return this entire package to the front desk. If you would like
to participate but have additional questions, my phone number during normal working
hours is (909) 824-4643, and during non-working hours I can be reached at (909) 8226567. Thank you for your time.
Sincerely,

Leslie Nazaroff, DrPH-(candidate)
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Appendix E
ID#____ /1-3
ARTHRITIS IMPACT MEASUREMENT SCALES 2
(AIMS2)
AIMS2 Copyright 1990 Boston University

Instructions: Please answer the following questions about your health. Most questions ask about your
health during the past month. There are no right or wrong answers to the questions and
most can be answered with a simple check (X). Please answer every question.
Please begin by providing the following information about yourself.
Name:

Today's Date:
Month

Address:

Number

Street

Apt.#

Uty

State

Zip

Phone: (Area Code 1

Day

Year

Number

Please check ( X ) the most appropriate answer for each question.
These questions refer to MOBILITY LEVEL

DURING THE PAST MONTH . . .
1.

2.

3.

4.

5.

All
Days,

Most
Days2

Some
DaySj

Few
Days4

No
Days5

How often were you physically able to
drive a car or use public transportation?

/4

How often were you out of the house
for at least part of the day?

/5

How often were you able to do
errands in the neighborhood?

/6

How often did someone have to assist
you to get around outside your home?

/7

How often were you in a bed or chair
for most or all of the day?

/8

This question refers to your CURRENT HEALTH

Very
satisfied,

6.

How satisfied are you with
your HEALTH NOW?

Somewhat
satisfied2

Neither
satisfied
nor
Somewhat
Very
dissatisfiedj dissatisfied^ dissatisfied,

/9
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Please check ( X ) the most appropriate answer for each question.
These questions refer to WALKING AND BENDING.
All
Most
DURING THE PAST MONTH . . .
Days, Days2
7. Did you have trouble doing vigorous activities
such as running, lifting heavy objects, or
participating in strenuous sports?

Some
Days3

Few
Days4

No
Days5

/10

8. Did you have trouble either walking several
blocks or climbing a few flights or stooping?

/II

9. Did you have trouble bending, lifting or stooping?

/12

10. Did you have trouble either walking one block or
climbing one flight of stairs?

/13

11. Were you unable to walk unless assisted by
another person or by a cane, crutches, or walker?

/14

These questions refer to HAND AND FINGER FUNCTION
All
Most
DURING THE PAST MONTH . . .
Days, Days2
12. Could you easily write with a pen or pencil?

Some
Days3

Few
Days4

No
Days5
/15

13. Could you easily button a shirt or blouse?

/16

14. Could you easily turn a key in a lock?

/17

15. Could you easily tie a knot or a bow?

/18

16. Could you easily open a new jar of food?

/19

These questions refer to ARM FUNCTION
DURING THE PAST MONTH . . .
17. Could you easily wipe your mouth with a
napkin?

All
Days,

Most
Days2

Some
Days3

Few
Days4

No
Days5
/20

18. Could you easily put on a pullover sweater?

/21

19. Could you easily comb or brush your hair?
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20. Could you easily scratch your low back with
your hand?

/23

21. Could you easily reach shelves that were
above your head?

/24
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Please check ( X ) the most appropriate answer for each question.
These questions refer to SELF-CARE TASKS
Very
Almost
DURING THE PAST MONTH . . .
Always, Often2 Sometimes^eve^
22. Did you need help to take a bath or a shower?

Never5
/25

23. Did you need help to get dressed?

/26

24. Did you need help to use the toilet?

m

25. Did you need help to get in or out of bed?

/28
AIMS

These questions refer to HOUSEHOLD TASKS
Very
Almost
Always, Often2 Sometimes3Never4

DURING THE PAST MONTH . . .
26. If you had the necessary transportation,
could you go shopping for groceries
without help?

Never5

/29

27. If you had kitchen facilities, could you prepare
your own meals without help?

/30

28. If you had household tools an appliances, could
you do your own housework without help?

/31

29. If you had laundry facilities, could you do your
own laundry without help?

/32

These questions refer to SOCIAL ACTIVITY
DURING THE PAST MONTH . . .
30. How often did you get together with friends or
relatives?

All
Days,

Most
Days2

Some
Days3

Few
Days4

No
Days5
/33

31. How often did you have friends or relatives over
to your home?

/34

32. How often did you visit friends or relatives at
their home?

/35

33. How often were you on the telephone with close
friends or relatives?

/36

34. How often did you go to a meeting of a church,
club, team or other group?

/37
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Please check ( X ) the most appropriate answer for each question.
These questions refer to SUPPORT FROM FAMILY AND FRIENDS
Very
Almost
DURING THE PAST MONTH . . .
Always, Often2 Sometimes^eve^
35. Did you feel that your family or friends would
be around if you needed assistance?

Never5
/38

36. Did you feel that your family or friends were
sensitive to your personal needs?

/39

37. Did you feel that your family or friends were
interested in helping you solve problems?

/40

38. Did you feel that your family or friends
understood the effects of your arthritis?

/41
AIMS

These questions refer to ARTHRITIS PAIN
DURING THE PAST MONTH . . .
39. How would you describe the arthritis pain you
usually had?

Severe,Moderate2 Mild3 Very Mild4 None5
/42

All
Days,

Most
Days2

Some
Days3

Few
Days4

No
Days5

40. How often did you have severe pain from
your arthritis?

/43

41. How often did you have pain in two or more
joints at the same time?

/44

42. How often did your morning stiffness last more
than one hour from the time you woke up?

/45

43. How often did your pain make it difficult for you
to sleep?

/46

Please provide the following information
about yourself:
44. What is your age?

WhitCj
Black2
Hispanic3
Asian or Pacific Islander4

/47

male,
45. What is your sex?

46. What is your racial background?

female2

American Indian or Alaskan Native5

/48

Other6
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/49

49. What is your approximate family
income including wages, disability
payment, retirement income and
welfare?

Please provide the following information about
yourself:
47. What is your current marital status?
Married,
Separated2
Divorced3
Widowed4
Never married5

$10,000,
Less than
/52
$10,000 - $19,0002
$20,000 - $29,0003
$30,000 - $39,0004
$40,000 - $49,0005
$50,000 - $59,0006
$60,000 - $69,0007
More than
$70,000g
Disease Duration:
50. How long have you been diagnosed with
rheumatoid arthritis?

/50

48. What is the highest level of education you
received?
Less than seven years of school,
Grades seven through nine2
Grades ten through eleven.
High school graduate4
One to four years of college5
College graduate6
Professional or graduate school7

/51
< 1
1-3
4-6
7-9
>9

year,
years2
years3
years4
years5

/53

Physical Activity Assessment
Please check ( X ) the most appropriate answer for each question.
51. Which of the following exercises do you perform on a regular basis? (answer all that apply)

None,

1-2 times 3-4 times 5-6 times
weekly2 weekly3 weekly4

Daily5

Stretching and flexibility:
/54

Range of motion,
Other2______________
(Please list)

Aerobic:
/55

Walking,
Running2
Swimming3
Stationary bicycling4
Bicycling5
Aerobics (to music)6
Other7____________
(Please list)

Strength training:
/56

Calisthenics !
Weight training2
Other3________
(Please list)
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Please check ( X ) the most appropriate answer for each question.
52. How long are your exercise sessions?
None,

1-15
minutes2

15-30
minutes3

31-45
minutes4

At least
46-60
minutes5

Stretching and flexibility:
Range of motion,
Other2______________
(Please list)

/57

Aerobic:
Walking,
Running.,
Swimming3
Stationary bicycling4
Bicycling5
Aerobics (to music)6
Other7 _________
(Please list)

/58

Strength training:
Calisthenics i
Weight training2
Other3________
(Please list)

/59

Patient Global Assessment
Poor,

Fair2

Good3

Very
good4

53. What is your overall assessment
of your current condition?

Excellent
/60

Patient Weight Status
Yes

No2

54. Do you consider yourself currently
overweight for your height and age?

/61

55. What is your current weight?

pounds

/62

56. What is your current height?

/63

Lifestyle
Yes
57. Have you made any new lifestyle changes within
the last six months?
(for example, a new diet or exercise program)

If yes, be specific:
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No2
/64

Medication Assessment
58. Regarding your rheumatoid arthritis only, please check (X) all that apply for each of the following
medications you are currently taking. Also indicate milligrams (mg) and how many per dose for
each medication you currently take for your rheumatoid arthritis:
Please How many
list
do you
take?2
mg.

Once
Daily3

2 times
Daily4

3 times
Daily5

4 times
Daily6

Not
very
often,

1-3
weekly8

Aspirin
Aspirin: Ancasal,
ASA, Ecotrin, Empirin,
or any over the counter
brand (eg., Bayer)
Salsalate: Disalcid
NSAIDs
Diclofenac: Voltaren
Fenoprofen calcium:
Nalfon
Ibuprofen: Motrin,
Rufen
Indomethacin: Indocid,
Indocin
Ketoprofen: Orudis
Ketorolac: Toradol
Meclofenamate:
Meclamen
Naproxen: Anaprox,
Naprosyn
Piroxicam: Pel dene
Tolmetin sodium:
Tolectin
Steroids
Prednisone: Deltasone,
Meticorten, Orasone
SAARDs
Auranofin: Ridaura
Aurothioglucose:
Myochrysine,
Solganal
Azathioprine: Imuran
Cyclosporin:
Sandimmune
Hydroxychloroquine:
Plaquenil
Methotrexate: Folex,
Mexate
Myochrysine
Penicillamine
Analgesics
Darvocet-N-50
Darvocet-N-100
Tylenol (reg)
Tylenol (ES)
Tylenol #3
Tylenol #4
Vicodin/Norcet

59.

4-5
weekly9
/65

/66

/67

768

769

Have you ever been hospitalized for any of the above medications? yes!

130

no2

/70

Rapid Assessment of Disease Activity in Rheumatology (RADAR)
Please answer these questions about your arthritis.
60. In general, how active has your arthritis
been over the past six months? Mark ( X )
on the scale below at the point which best
describes the level of arthritis activity you
have had.
Extremely
Not active
at afl
active
/71
61. How active is your arthritis today in terms
of joint tenderness and swelling? Mark (
X ) on the scale below at the appropriate
point.
Not active
Extremely
at all
Active

65.

Please indicate below the amount of pain
and/or tenderness you are having today
in each of the joint areas listed below.
Mark the amount by circling the correct
number.
The choices are:
0
1
2
3

62. How much arthritis pain do you feel today?
Mark ( X ) on the scale below at the
appropriate point.
No pain
Very Severe
Pain

Joints

/73

/74

If Yes, how long did this extra
stiffness last?
Less than 30 minutes
30 minutes to an hour
.2
1- 2 hours
2-4 hours
A
More than 4 hours
.5
All day
.6
64.

I.
II.

III.
IV.

/75
Please check (X) the one statement that
best describes your abilities today.
/76
Able to carry on all usual duties
without limitation.
_______
Able to conduct normal activities despite
handicap of discomfort or limited
mobility of one or more joints. __
1
Able to perform few or none of the
duties of your usual occupation.__
-3
Largely confined to bed and chair
with little or no self care.
4

no pain/tenderness
mild pain/tenderness
moderate pain/tendemess
severe pain/tendemess

For those areas marked with (*), think of
the joint in the group that bothers you
the most today and give a score for that
joint. Be sure to mark both right side
and left side separately.

/72

63. Were your joints stiff when you woke up
today?
Yes
No
.2

=
=
=
=

Right Side
None,

Shoulders
0
Elbows
0
Wrists
0
Hand Knuckles* 0
Finger Knuckles* 0
Hips
0
Knees
0
Ankles
0
Ball of Foot*
0
Toe Knuckles* 0

Joints

Moderate,

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

Severe1

3 hi
3
3
3
3
3
3
3
3
3

Left Side
None1

Shoulders
0
Elbows
0
Wrists
0
Hand Knuckles* 0
Finger Knuckles* 0
Hips
0
Knees
0
Ankles
0
Ball of Foot*
0
Toe Knuckles* 0
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Mild,

Mild,

Moderate,

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

Severe,,

3 /78
3
3
3
3
3
3
3
3
3

Arthritis Self-Efficacy Scale
Please answer these questions about your arthritis.
Self-efficacy pain subscale
In the following questions, we'd like to know how your arthritis pain affects you. For each of
the following questions, please circle the number which corresponds to your certainty that you
can now perform the following tasks.
AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN:
Very
Moderately
Very
uncertain
uncertain
certain
66. Decrease your pain quite a bit?
10 20 30 40 50 60 70 80 90 100
67.

Continue most of your daily activities?

10

20 30 40 50 60 70 80 90 100

68.

Keep arthritis pain from interfering with your sleep?

10

20 30 40 50 60 70 80 90 100

69.

Make a small-to-moderate reduction in your arthritis
10
pain by using methods other than taking extra medication?

20 30 40 50 60 70 80 90 100

70.

Make a large reduction in your arthritis pain by
using methods other than taking extra medication?

10 20 30 40 50 60 70 80 90 100

Self-efficacy function subscale
We would like to know how confident you are in performing certain daily activities. For each
of the following questions, please circle the number which corresponds to your certainty that you
can perform the tasks as of now, without assistive devices or help from another person. Please
consider what you routinely can do, not what would require a single extraordinary effort.
AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN:
Very
Moderately
Very
uncertain
uncertain
certain
71. Walk 100 feet on flat ground in 20 seconds?
10 20 30 40 50 60 70 80 90 100
72.

Walk 10 steps downstairs in 7 seconds?

10

20 30 40 50 60 70 80 90 100

73.

Get out of an armless chair quickly, without using
your hands for support?

10

20 30 40 50 60 70 80 90 100

74.

Button and unbutton 3 medium-size buttons in a row
in 12 seconds?

10

20 30 40 50 60 70 80 90 100
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Please circle the number that corresponds with your certainty that you can preform the following tasks.

AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN:
Very
Moderately
Very
uncertain
uncertain
certain
10 20 30 40 50 60 70 80 90 100

75.

Cut 2 bite-size pieces of meat with a knife and
fork in 8 seconds?

76.

Turn an outdoor faucet all the way on and
all the way off?

10

20 30 40 50 60 70 80 90 100

77.

Scratch your upper back with both your
right and left hands?

10

20 30 40 50 60 70 80 90 100

78.

Get in and out of the passenger side of a car without
assistance from another person and without
physical assistance?

10

20 30 40 50 60 70 80 90 100

79.

Put on a long-sleeve front-opening shirt or
blouse (without buttoning) in 8 seconds?

10

20 30 40 50 60 70 80 90 100

Self-efficacy other symptoms subscale
In the following questions, we'd like to know how you feel about your ability to control your
arthritis. For each of the following questions, please circle the number which corresponds to the
certainty that you can now perform the following activities.

AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN:
Very
Moderately
Very
uncertain
uncertain
certain
10 20 30 40 50 60 70 80 90 100

80.

Control your fatigue?

81.

Regulate your activity so as to be active without
aggravating your arthritis?

10

82.

Do something to help ourself feel better if you are
feeling blue?

10 20 30 40 50 60 70 80 90 100

83.

As compared with other people with arthritis like
yours, manage arthritis pain during your
daily activities?

10 20 30 40 50 60 70 80 90 100

84.

Manage your arthritis symptoms so that
you can do the things you enjoy doing?

10

20 30 40 50 60 70 80 90 100

85.

Deal with the frustration of arthritis?

10

20 30 40 50 60 70 80 90 100
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20 30 40 50 60 70 80 90 100

Arthritis Outcome Expectation Scale
Please answer these questions about your arthritis.

Outcome expectation subscale
In the following questions, we'd like to know your beliefs about how your lifestyle affects your
arthritis. For each of the following questions, please circle the number which corresponds to
your certainty that you can now perform the following tasks.
AS OF NOW, HOW CERTAIN ARE YOU THAT YOU CAN:
Very
Moderately
Veiy
uncertain
uncertain
certain
86. Reduce your symptoms of arthritis
10 20 30 40 50 60 70 80 90 100
by exercise?
87.

Reduce your symptoms of arthritis
by eating certain foods?

10

20 30 40 50 60 70 80 90 100

88.

Reduce your symptoms of arthritis
by avoiding certain foods?

10

20 30 40 50 60 70 80 90 100

^Jlianh you for compietiny this cfruedtionnalre!
Please be sure to answer the Nutrition Profile pamphlet!

134

Nutrition
Profile

Example----------------------------------------If you normally drink one serving. */2 cup (4 oz.) of orange juice each
morning, you would fill in circle number CD and CE> on line 1. of the
answer card. If you have been eating three and one half servings of
pancakes each Saturday morning, then you would fill in circles 05, cs>,
and ® on line 11. on the answer card.

r Introduction
Think back to the last week or so. How well have you been
eating? Like most people, you may have a difficult time
determining the answer to this question. Completing this
simple food frequency survey answers this question. You
will leam about the factors in your diet affecting overall
health, including your risk for heart disease and cancer.

Fruits

Instructions--------------------------------Write your name and address on the attached answer card,
then mark your Social Security or ID number, gender, and
present condition (if applicable) in the spaces provided.

2. Other fresh or dried fruit - sm. apple, sm. banana,
large peach, 2 plums, 1 C grapes, 1 oz. raisins, or
other dried fruit

^FfNumber2

Right

X

Wrong

Wrong

cm

Wrong

3. Canned fruit - Vz C applesauce, peaches, pears,
or fruit cocktail
4. Fruit juice, no added sugar •
1 C apple, grape, or pineapple

Marks should fill the circle completely.

Dairy Products
Completing the Nutrition Profile__
It is important to complete this section properly. Think
back through the last week or so, as you consider each food
group listed. Notice the kind of foods and serving sizes
listed within the group, then mark on the answer card the
number of servings and how often you eat them. Mark your
responses on the line corresponding to the number of the
food group you have chosen. If a type of food you eat is
not listed, compare it to examples given and choose the
appropriate similar category. Skip any food group you do
not eat.

■........................... . .1.

1.|©|*|CD |CD|® |CE>|® |

If you mark more than one number of servings on one line they will
be added together. For example, if you mark CD and CD, these will be
added to equal 9 servings of this food group.
Leave blank any food group you do not eat.

1. Citrus, berries, melons - 1 orange, Vz grapefruit,
1 C strawberries, 1/4 cantaloupe, or Vz C orange juice

Use a No. 2 pencil only. Erase changes cleanly.

MARK NUMBER OF SERVINGS & HOW OFTEN
1/2 1 2 3 4 5 6
Day Wk Mo

5. Nonfat -1C skim milk, nonfat plain
yogurt, or buttermilk, 1 oz. nonfat cheese
6. Low fat - 1 C 1% or 2% milk, low fat plain yogurt,
Vz C low fat cottage cheese, or 1 oz. low fat cheese
such as mozzarella
7. High fat - 1 C whole milk or plain yogurt,
Vz C creamed cottage cheese, 1 oz. regular cheese
such as American, Swiss, or cheddar
(For nonfat frozen desserts see question numbers 23 & 24.)

Grain Products
8. Whole-grain - 2 slices bread,
1 muffin, 3/4 C dry cereal, 2/3 C cooked cereal,
brown rice, or com

>

T3
T3

ft)

9. Sugar-sweetened cereal - 3/4 C sugar coated
flakes, or sugary children’s cereals

2

10. Other grains - 2 slices white bread, 1 roll, 1 bagel,
1 hamburger bun, 2 tortillas, 1 oz. crackers,
2/3 C white rice, 1 C plain pasta, or 4 C popcorn
11. Quick breads - 1 pancake, muffin, biscuit,
croissant, sm. waffle, or l"x2" combread

Vegetables

7

12. Vitamin A rich - dark yellow
and green vegetables such
as 2/3 C cooked greens,
y
carrots, or 1 spear broccoli
13. Starchy vegetables - Vz C cooked winter squash,
potato, yams, or peas
14. Other vegetables -1C fresh or Vz C cooked
green beans, cabbage, salad greens, tomato,
squash, or 1 C tomato juice

x
►n

Protein Rich Foods

Mixed Dishes and Snacks

15. Fish and seafood - 3 02. salmon, shrimp, oysters,~
white fish, or water pack tuna
16. Low fat meats - 3 oz. skinless poultry, lean wild
game, or veal
17. Medium fat meats - 3 oz. lean beef, pork, poultry,
or oil packed tuna (drained)
18. High fat meats - 3 oz. beef, sausage, luncheon
meat, meat loaf, hamburger, frankfurter, bacon,
fried chicken, or fried fish
19. Legumes -1C cooked pinto beans, white beans,
garbanzos, lentils, or split peas
20. Egg - 1 large egg (if fried, count fat below in Fat
Rich Foods)
21. Vegetarian entree (low fat) - 1 vegetable burger
patty, 3 oz. gluten product, loaf without eggs or
cheese, or low fat tofu
22. Vegetarian entree (high fat) - 3 oz. soy burger or
sausage product, loaf with eggs and cheese, or tofu.

Nonfat, Low fat, and
Diet Foods
0\

K \

23. V2 C low fat ice cream, frozen yogurt, sherbet
24. V2 C nonfat ice cream, or frozen yogurt
25. 1 fat free pastry, or 2 fat free cookies
26. 1 T low fat, low calorie salad dressing, or
reduced fat mayonnaise
27. 1 T fat free or diet salad dressing, or
nonfat mayonnaise

; 31. Pasta - 2/3 C macaroni and cheese,
lasagna, spaghetti with tomato and cheese sauce,
j
or 1 C pasta salad
^

32. Hot dishes - 1 C chili with beans, beef and
vegetable stew, or pot pie

j

33. Ethnic foods - 1 taco, enchilada, slice pizza,
or sm. burrito

i 35. Soup (high fat) - cream, or meat soups

!

36. Snacks - 1 oz. snack crackers, com chips, potato
chips, or 1 sm. serving French fries

Desserts
j 37. Cream desserts - z/3 C ice cream, sm. milk shake,
V2 C pudding, sm. slice cheesecake, or
ty3 C mousse
I 38. Baked foods - 2 cookies, 1 sweet roll, doughnut,
pastry, slice angel food cake, or V2 slice cake
39. Pie (fruit) - 1 slice apple, cherry, peach, or berry
40. Pie (other) - 1 slice pumpkin, cream, custard,
or nut
41. Chocolates - 1 oz. chocolate bar, almond roca,
or chewy caramel chocolate mixed bar
42. Sugar and sweets (nonfat) - 2 T sugar, jam,
honey, or 1 oz. candy (include sugar added to coffee,
tea, cereal, etc.)

Drinks
43. Sugar-sweetened -1C punch,
lemonade, or 12 oz. can soda pop

28. Vegetable fats -IT vegetable oil, margarine, or
mayonnaise, or 2 T salad dressing

44. Caffeinated beverages -1C coffee, tea, or
12 oz. can of any drink containing caffeine (include
beverages listed above)

30. Other fats, nuts, seeds - 2 T of nuts or seeds,
1 T peanut butter, V4 avocado, or 10 olives

Questionnaire

34. Soup (low fat) -1C chicken noodle,vegetable,
or tomato

Fat Rich Foods

29. Animal fats -IT butter, or lard, 2 T cream, cream
cheese, sour cream, or V4 C gravy made with fat

Nutrition
Profile

45. Alcohol - 12 oz. beer, 3/4 oz. wine, 1.5 oz. liquor,
or 10 oz. wine cooler
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